Document:

Exhibit

Exhibit 10.5

CSRA INC.

2015 OMNIBUS INCENTIVE PLAN

SERVICE BASED RESTRICTED STOCK UNIT

AWARD AGREEMENT

		
	1.
	Grant of Award.

This Agreement (“Agreement”) is made and entered into as of «Grant_Date_x» (the “Grant Date”) by and between CSRA Inc., a Nevada corporation (the “Company”), and «Name_x», a full-time employee of the Company and/or one or more of its subsidiaries (the “Employee”).
This Agreement granting the Employee an award under the Plan (the “Award”) shall be subject to all of the terms and conditions set forth in the CSRA Inc. 2015 Omnibus Incentive Plan (the “Plan”) and this Agreement.  Except as defined in Appendix A, capitalized terms shall have the same meanings ascribed to them under the Plan.

This Award is subject to the data privacy provisions set forth in Appendix B.
Award Granted: «Shares_Granted_x» Restricted Stock Units (the “RSUs”) 
Upon each of the dates indicated below (each, a “Vesting Date”), subject to the terms and conditions set forth herein, the RSUs shall vest with respect to the number indicated below across from such date:
                      Number of RSUs Vesting                                         Date
TBD    TBD            

		
	2.
	Settlement of RSUs.

(a)    The RSUs shall be settled by the Company delivering to the Employee (or after the Employee’s death, the beneficiary designated by the Employee for such purpose), on the applicable Scheduled Settlement Date, a number of RSU Shares equal to the number of RSUs vesting on such date, together with any related Dividend Equivalents.
(b)    Except as otherwise provided in this Agreement, the RSUs shall be settled on the applicable Scheduled Settlement Date.
		
	3.
	Effect of Termination of Employment; Approved Termination; Change in Control; Recoupment and Forfeiture.

1

(a)    Age 62 or Older Other than for Cause, death or Disability with at least 10 Years of Service; Approved Termination.  If, prior to the settlement of the RSUs in full:
(i)    the Employee’s status as an employee of the Company or any of its subsidiaries is terminated at age 62 or older for no reason, or for any reason other than Cause, death or Disability, and the Employee shall have been (or for any other purpose shall have been treated as if he or she had been) a continuous employee of the Company or its subsidiaries for at least 10 years immediately prior to the date of termination of employment status; or
(ii)    the Employee’s status as an  employee of the Company or any of its subsidiaries is terminated at any time during the term of the Award and such termination is specifically approved by the Committee for purposes of this Section 3(a),
then, as soon as practicable after the Employee’s status as an employee of the Company or its subsidiaries is terminated (the “Employment Termination Date”), the Company shall settle a fraction of the RSUs and any related Dividend Equivalents.  The fraction of the RSUs settled will equal (A) minus (B), where (A) equals the product of (x) the total number of RSUs granted hereunder and (y) a fraction, the numerator of which shall be the number of full months of continuous service with the Company or its subsidiaries that the Employee has completed since the Grant Date  and the denominator of which shall be 24, and where (B) equals any RSUs that have vested and been settled prior to the termination date.
(b)    Leave of Absence.  If, prior to the settlement of the RSUs in full, the Employee is granted a leave of absence (including a military leave of absence), the Employee and the Company each reasonably anticipate that the Employee will return to active employment and either (x) the leave of absence is to be for not more than six months or (y) at all times during the leave of absence the Employee has a statutory or contractual right to return to work, then:
(i)    while on leave of absence the Employee shall be treated as if he were an active employee;
(ii)    if the Employee’s leave of absence is terminated before the applicable Scheduled Settlement Date and the Employee does not timely return to active employment, the date of the end of the leave of absence shall be treated as the date on which the Employee has a termination of employment;
(iii)    if the Employee’s leave of absence is terminated before the applicable Scheduled Settlement Date and the Employee timely returns to active employment, he shall be treated as if active employment had continued uninterrupted during the leave of absence; and
(iv)    if the Employee’s leave of absence continues to the applicable Scheduled Settlement Date, the applicable number of RSUs shall be settled on such date.

2

(c)    Death or Disability.
(i)    Notwithstanding anything to the contrary in this Agreement, if, prior to the settlement in full of the RSUs, the Employee’s status as an employee of the Company or any of its subsidiaries is terminated by reason of death of the Employee, then, one calendar month after such death, the Company shall complete the settlement in full of any remaining unsettled RSUs and any related Dividend Equivalents.
(ii)    If, prior to the settlement in full of the RSUs, the Employee’s status as an employee of the Company or any of its subsidiaries is terminated by reason of the Disability of the Employee, then, one calendar month after the Employment Termination Date, the Company shall complete the settlement in full of any remaining unsettled RSUs and any related Dividend Equivalents.
(iii)    If settlement is by reason of termination due to death, settlement shall be to the beneficiary designated by the Employee for such purpose.
(d)    Cancellation of RSUs upon Other Termination of Employment.  If, prior to the settlement in full of the RSUs, the Employee’s status as an employee of the Company or any of its subsidiaries is voluntarily or involuntarily terminated other than pursuant to Section 3(a) or (c) hereof, then the RSUs and all related Dividend Equivalents shall automatically be cancelled as of the close of business on the Employment Termination Date.
(e)    Change in Control.  Upon a Change in Control that occurs while Employee is employed by the Company or its subsidiaries, any remaining unsettled RSUs and any related Dividend Equivalents shall be settled in full within 10 days after the Change in Control. 
(f)    Recoupment and Forfeiture.  Settlement of all or a portion of the Award pursuant to this Section 3 is subject to the forfeiture provisions of this Section 3.  Settlement of all or a portion of the Award is subject to recoupment by the Company pursuant to Section 5.
		
	4.
	Withholding and Taxes.

(a)    If the Company and/or the Employer are obligated to withhold an amount on account of any federal, state or local tax imposed as a result of the grant or settlement of the RSUs pursuant to this Agreement (collectively, “Taxes”), including, without limitation, any federal, state or other income tax, or any F.I.C.A., state disability insurance tax or other employment tax (the date upon which the Company and/or the Employer becomes so obligated shall be referred to herein as the “Withholding Date”), then the Employee shall pay to the Company on the Withholding Date, the minimum aggregate amount that the Company and the Employer are so obligated to withhold, as such amount shall be determined by the Company (the “Minimum Withholding Liability”), which payment shall be made by the automatic cancellation by the Company of a portion of the RSU Shares; provided that the Company is not then prohibited from purchasing or acquiring such shares of Common Stock (such shares to be valued on the basis of the aggregate Fair Market Value thereof on the Withholding Date, plus the value of the Dividend Equivalents associated with such shares on the Withholding Date); and provided further that the RSU Shares to be cancelled 

3

shall be those that would otherwise have been delivered to the Employee the soonest upon settlement of the RSUs; and provided further, however, that the Employee may, on or before the Withholding Date, irrevocably elect to instead pay to the Company, by check or wire transfer delivered or made within one business day after the Withholding Date, an amount equal to or greater than the Minimum Withholding Liability.
(b)    The Employee acknowledges that neither the Company nor the Employer has made any representation or given any advice to the Employee with respect to Taxes.
		
	5.
	Recoupment and Forfeiture.

(a)    Refund of Stock Value; Forfeiture of RSUs.
(i)    Refund of Stock Value.  If the Employee breaches any of the covenants set forth in Section 5(b)(i), (ii) or (iii) hereof during the Applicable Restrictive Period for any Settlement Date, then, if the RSUs were settled within the one year period prior to the occurrence of such event, the Employee shall immediately deliver to the Company an amount in cash equal to the (i) aggregate Fair Market Value, determined as of such Settlement Date, of all RSU Shares which were delivered to the Employee or cancelled in payment of Taxes on such Settlement Date and (ii) Dividend Equivalents paid to the Employee in respect of the RSU Shares.
(ii)    Forfeiture of RSUs.  If the Employee breaches any of the covenants set forth in Section 5(b)(i), (ii) or (iii) hereof prior to the Settlement Date for the RSUs, the RSUs and all related Dividend Equivalents shall be terminated and forfeited.  
(b)    Triggering Events.  The events referred to in Sections 3(f) and 5(a) hereof are as follows:
(i)    Non-Disclosure and Non-Use of Confidential Information.  The Employee agrees not to disclose, use, misappropriate, communicate, disseminate, copy or duplicate or otherwise permit the use, disclosure, misappropriation, communication, dissemination, copying or duplication of any Confidential Information (other than in connection with authorized activities conducted in the course of the Employee’s employment at the Company for the benefit of the Company) during the period of including during his/her employment with the Company or at any time thereafter. The Employee agrees to take all reasonable steps and precautions to prevent any unauthorized disclosure, use, misappropriation, communication, dissemination copying or duplication of Confidential Information and to return all Confidential Information to the Company promptly upon Employee’s termination of employment.
(ii)    Non-Solicitation of the Company’s Employees, Clients, and Prospective Clients.  During the time of the Employee’s employment and for a period of 24 months thereafter, the Employee shall not, without the express, prior written 

4

consent of the Company’s General Counsel, engage in any of the conduct described in paragraphs (A) and (B) below, either directly or indirectly, individually or as an employee, agent, contractor, consultant, member, partner, officer, director or stockholder (other than as a stockholder of less than 5% of the equities of a publicly held corporation) or in any other capacity for any person, firm, partnership or corporation:
(A)    hire, attempt to hire or assist any other person or entity in hiring or attempting to hire any current employee of the Company or any person who was a Company employee within the 6-month period preceding such hiring or attempted hiring;
(B)    solicit, divert or cause a reduction in the business or patronage of any Client or Prospective Client. 
(iii)    Non-Competition.  During the time of the Employee’s employment and for a period of 12 months thereafter, the Employee shall not, without the express, prior written consent of the Company’s General Counsel, either directly or indirectly, as an employee, agent, contractor, consultant, partner, member, officer, director or stockholder (other than as a stockholder of less than 5% of the equities of a publicly traded corporation), wherever the Company is marketing or providing its services or products, participate in any activity as, or for, a Competitor of the Company which is the same or similar to the activities in which the Employee was involved at the Company.
(c)    Waiver of Recoupment.  Notwithstanding the foregoing, the Employee shall be released from (i) all of his or her obligations under Section 5(a) hereof in the event that a Change in Control occurs within three years prior to the Employment Termination Date, and (ii) some or all of his or her obligations under Section 5(a) hereof in the event that the Committee (if the Employee is an executive officer of the Company) or the Company’s Chief Executive Officer (if the Employee is not an executive officer of the Company) shall determine, in their respective sole discretion, that such release is in the best interests of the Company.
(d)    Effect on Other Rights and Remedies.  The rights of the Company set forth in this Section 5 shall not limit or restrict in any manner any rights or remedies which the Company or any of its affiliates may have under law or under any separate employment, confidentiality or other agreement with the Employee or otherwise with respect to the events described in Section 5(b) hereof.
(e)    Reasonableness.  The Employee agrees that the terms and conditions set forth in this Section 5 are fair and reasonable and are reasonably required for the protection of the interests of the Company.  If, however, in any judicial proceeding any provision of this Section 5 is found to be so broad as to be unenforceable, the Employee and the Company agree that such provision shall be interpreted to be only so broad as to be enforceable.

5

(f)    Clawback.  As an additional condition of receiving this Award, the Employee agrees and acknowledges that the Award shall be subject to repayment to the Company in whole or in part in the event of a financial restatement or in such other circumstances as may be required by applicable law or as may be provided in any clawback policy that is adopted by the Company.
		
	6.
	Registration of Units.

The Employee’s right to receive the RSU Shares shall be evidenced by book entry (or by such other manner as the Committee may determine).
		
	7.
	Certain Corporate Transactions.

In the event that the outstanding securities of any class then comprising the RSU Shares are increased, decreased or exchanged for or converted into cash, property and/or a different number or kind of securities, or cash, property and/or securities are distributed in respect of such outstanding securities, in either case as a result of a reorganization, merger, consolidation, recapitalization, reclassification, dividend (other than a regular, quarterly cash dividend) or other distribution, stock split, reverse stock split or the like, then, unless the Committee shall determine otherwise, the term “RSU Shares,” as used in this Agreement, shall, from and after the date of such event, include such cash, property and/or securities so distributed in respect of the RSU Shares, or into or for which the RSU Shares are so increased, decreased, exchanged or converted.
		
	8.
	Shareholder Rights.

The Employee shall have no rights of a shareholder with respect to RSU Shares subject to this Award unless and until such time as the Award has been settled by the transfer of shares of Common Stock to the Employee.
		
	9.
	Assignment of Award.

Except as otherwise permitted by the Committee, the Employee’s rights under the Plan and this Agreement are personal; no assignment or transfer of the Employee’s rights under and interest in this Award may be made by the Employee other than by will or by the laws of descent and distribution.
		
	10.
	Notices.

Unless the Company notifies the Employee in writing of a different procedure, any notice or other communication to the Company with respect to this Award shall be in writing and shall be:
(a)    by registered or certified United States mail, postage prepaid, to CSRA Inc., Attn: Corporate Secretary, 3170 Fairview Park Drive, Falls Church, VA 22042; or
(b)    by hand delivery or otherwise to CSRA Inc., Attn: Corporate Secretary, 3170 Fairview Park Drive, Falls Church, VA 22042.

6

Any notices provided for in this Agreement or in the Plan shall be given in writing and shall be deemed effectively delivered or given upon receipt or, in the case of notices delivered by the Company to the Employee, five days after deposit in the United States mail, postage prepaid, addressed to the Employee at the address specified at the end of this Agreement or at such other address as the Employee hereafter designates by written notice to the Company.
		
	11.
	Stock Certificates.

Certificates representing the Common Stock issued pursuant to the Award will bear all legends required by law and necessary or advisable to effectuate the provisions of the Plan and this Award.  The Company may place a “stop transfer” order against shares of the Common Stock issued pursuant to this Award until all restrictions and conditions set forth in the Plan or this Agreement and in the legends referred to in this Section 11 have been complied with.
		
	12.
	Successors and Assigns.

This Agreement shall bind and inure to the benefit of and be enforceable by the Employee, the Company and their respective permitted successors and assigns (including personal representatives, heirs and legatees), except that the Employee may not assign any rights or obligations under this Agreement except to the extent and in the manner expressly permitted herein.
		
	13.
	Plan.

The RSUs are granted pursuant to the Plan, as in effect on the Grant Date, and are subject to all the terms and conditions of the Plan, as the same may be amended from time to time; provided, however, that no such amendment shall deprive the Employee, without his or her consent, of the RSUs or of any of the Employee’s rights under this Agreement.  The interpretation and construction by the Committee of the Plan, this Agreement and such rules and regulations as may be adopted by the Committee for the purpose of administering the Plan shall be final and binding upon the Employee.  Until the RSUs are settled in full, the Company shall, upon written request therefor, send a copy of the Plan, in its then-current form, to the Employee.
		
	14.
	No Employment Guaranteed.

No provision of this Agreement shall (a) be deemed to form an employment contract or relationship with the Company or any of its subsidiaries, (b) confer upon the Employee any right to be or continue to be in the employ of the Company or any of its subsidiaries, (c) affect the right of the Employer to terminate the employment of the Employee, with or without cause, or (d) confer upon the Employee any right to participate in any employee welfare or benefit plan or other program of the Company or any of its subsidiaries other than the Plan.  The Employee hereby acknowledges and agrees that the Employer may terminate the employment of the Employee at any time and for any reason, or for no reason, unless applicable law provides otherwise or unless the Employee and the Employer are parties to a written employment agreement that expressly provides otherwise.
		
	15.
	Nature of Company Restricted Stock Unit Grants.

7

The Employee acknowledges and agrees that:
(a)    the Plan was established voluntarily by the Company, it is discretionary in nature and it may be modified, suspended or terminated by the Company at any time, as provided in the Plan and this Agreement;
(b)    the Company grants RSUs voluntarily and on an occasional basis, and the receipt of the RSUs by the Employee does not create any contractual or other right to receive any future grant of RSUs, or any benefits in lieu of a grant of RSUs; 
(c)    all decisions with respect to future grants of RSUs by the Company will be made in the sole discretion of the Company; 
(d)    the Employee is voluntarily participating in the Plan; and
(e)    the future value of the RSUs is unknown and cannot be predicted with certainty.
		
	16.
	Governing Law; Consent to Jurisdiction.

This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Nevada, United States of America, excluding any conflicts or choice of law rule or principle that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.  Any action, suit or proceeding to enforce the terms and provisions of this Agreement, or to resolve any dispute or controversy arising under or in any way relating to this Agreement, may be brought in the state courts for the County of Washoe, State of Nevada, United States of America, and the parties hereto hereby consent to the jurisdiction of such courts.  If the Employee has received this or any other document related to the Plan translated into a language other than English, and the translated version is different than the English version, the English version will control.
		
	17.
	Entire Agreement; Amendment and Waivers.

This Agreement embodies the entire understanding and agreement of the parties with respect to the subject matter hereof, and no promise, condition, representation or warranty, express or implied, not stated or incorporated by reference herein, shall bind either party hereto.  None of the terms and conditions of this Agreement may be amended, modified, waived or canceled except by a writing, signed by the parties hereto specifying such amendment, modification, waiver or cancellation.  A waiver by either party at any time of compliance with any of the terms and conditions of this Agreement shall not be considered a modification, cancellation or consent to a future waiver of such terms and conditions or of any preceding or succeeding breach thereof, unless expressly so stated.
		
	18.
	Section 409A Compliance.

Payments under this Agreement are designed to be made in a manner that is exempt from or compliant with Section 409A of the U.S. Internal Revenue Code (the “Code”) as a “short-

8

term deferral,” and the provisions of this Agreement will be administered, interpreted and construed accordingly (or disregarded to the extent such provision cannot be so administered, interpreted, or construed).
Notwithstanding anything to the contrary in this Agreement, if, upon the advice of its counsel, the Company determines that the settlement of an RSU Share pursuant to this Agreement is or may become subject to the additional tax under Section 409A(a)(1)(B) of the Code or any other taxes or penalties imposed under Section 409A (“409A Taxes”) as applicable at the time such settlement is otherwise required under this Agreement, then such payment may be delayed to the extent necessary to avoid 409A Taxes.  In particular:
(a)    if the Employee is a specified employee within the meaning of Section 409A(a)(2)(B)(i) of the Code on the date of the Employee’s “separation from service” (other than due to death) within the meaning of Section 1.409A-1(h) of the Treasury Regulations, such settlement shall be delayed until the earlier of (i) the first business day following the expiration of six months from the Employee’s separation from service, (ii) the date of the Employee’s death, or (iii) such earlier date as complies with the requirements of Section 409A (the “Settlement Delay Period”); and
(b)    if all or any part of such RSU Share has been converted into cash pursuant to Section 7 hereof, then:
(i)    upon settlement of such RSU Share, such cash shall be increased by an amount equal to interest thereon for the Settlement Delay Period at a rate equal to the default rate credited to amounts deferred under the Company’s Deferred Compensation Plan; provided, however, that such rate shall be calculated on a monthly average basis rather than a daily basis; and
(ii)    the Company shall fund the payment of such cash to the Employee upon settlement of such RSU Share, including the interest to be paid with respect thereto (collectively, the “Delayed Cash Payment”), by establishing and irrevocably funding a trust for the benefit of the Employee, but only if the establishment of such trust does not result in any taxes or penalties becoming due under Section 409A(b).  Such trust shall be a grantor trust described in Section 671 of the U.S. Internal Revenue Code and intended not to cause tax to be incurred by the Employee until amounts are paid out from the trust to the Employee.  The trust shall provide for distribution of amounts to the Employee in order to pay taxes, if any, that become due on the amounts as to which payment is being delayed during the Settlement Delay Period pursuant to this Section 18, but only to the extent permissible under Section 409A of the U.S. Internal Revenue Code without the imposition of 409A Taxes.  The establishment and funding of such trust shall not affect the obligation of the Company to pay the Delayed Cash Payment pursuant to this Section 18.

9

IN WITNESS WHEREOF, the parties hereto have caused this Award Agreement to be duly executed as of the Grant Date.

EMPLOYEE                            CSRA INC.
___________________________________________    By:    ________________________
«Name_x»                                Name:                                      Title:                                      
	
	
	The Employee acknowledges receipt of the Plan and a Prospectus relating to this award, and further acknowledges that he or she has reviewed this Agreement and the related documents and accepts the provisions thereof.

___________________________________________
«Name_x»
ACCEPTANCE DATE

10

Appendix A

		
	1.
	Definitions.

For purposes of this Agreement:
(a)    “Applicable Restrictive Period” shall mean, with respect to each Settlement Date, the period set forth in Section 5(b)(i), (ii) or (iii) hereof, respectively.
(b)    “Cause” shall mean: (A) fraud, misappropriation, embezzlement or other act of material misconduct against the Company or any of its affiliates; (B) conviction of a felony involving a crime of moral turpitude; (C) willful and knowing violation of any rules or regulations of any governmental or regulatory body material to the business of the Company; or (D) substantial and willful failure to render services in accordance with the terms of his or her employment (other than as a result of illness, accident or other physical or mental incapacity), provided that (X) a demand for performance of services has been delivered to the Employee in writing by the Employee’s supervisor at least 60 days prior to termination identifying the manner in which such supervisor believes that the Employee has failed to perform and (Y) the Employee has thereafter failed to remedy such failure to perform.
(c)    “Client” means any client with respect to whom the Employee provided services, on behalf of whom the Employee transacted business, or with respect to whom the Employee possessed Confidential Information during the 12-month period preceding each of (i) the date the Employee engages in an act described in Section 5(b)(ii)(B) and (ii) the date of the termination of the Employee’s employment with the Company for any reason.
(d)    “Competitor” means an individual, business or any other entity or enterprise engaged or having publicly announced its intent to engage in business that is substantially similar to the Company’s business. For purposes of this Agreement, the parties specifically agree that: the Company is engaged in the business of providing technology-enabled solutions and services; that the Company’s capabilities include, but are not limited to, system design and integration, information technology and business process outsourcing, applications software development, Web and application hosting, mission support and management consulting; and that the Company actively solicits business and services clients located throughout the United States and the world.  A non-exhaustive list of the Company’s Competitors includes AAR Corporation, Booz Allen Hamilton Holding Corporation, CACI International, Engility Holdings, Harris Corporation, L-3 Communications Holdings, Leidos Holdings, ManTech International, Maximus, Rockwell Collins, SAIC, Unisys Corporation, or any subsidiary or affiliate thereof.
(e)    “Confidential Information” means all Company trade secrets, patents, copyrights, confidential or proprietary business information and data, sales and financial data, pricing information, manufacturing and distribution methods, information relating to the Company’s business plans and strategies including, but not limited to, customers and/or prospects, or lists thereof, marketing plans and procedures, research and development plans, methods of doing business, both technical and non-technical, information relating to the design, architecture, 

11

flowcharts, source or object code and documentation of any and all computer software products which the Company has developed, acquired or licensed or is in the process of developing, acquiring or licensing or shall develop, acquire or license in the future, hardware and database technologies or technological information, formulae, designs, process and systems information, intellectual property rights, and any other confidential or proprietary information which relates to the business of the Company or to the business of any client or vendor of the Company or any other party with whom the Company agrees to hold information in confidence, whether patentable, copyrightable or protectable as trade secrets or not.  Confidential Information does not include information which is (i) already known by the Employee without an obligation of confidentiality, (ii) publicly known or becomes publicly known through no unauthorized act of the Employee, (iii) rightfully received from a third party without an obligation of confidentiality, (iv) disclosed without similar restrictions by the Company to a third party (other than an affiliate or customer of the Company), or (v) approved by the Company, in writing, for disclosure.
(f)    “Employer” shall mean the Employee’s employer.
(g)    “Prospective Client” means any individual or enterprise who is not a Client but with whom the Company was in active business discussions or negotiations at any time during either (i) the date the Employee engages in an act described in Section 5(b)(ii)(B) or (ii) the 12-month period preceding the termination of the Employee’s employment with the Company for any reason and in each case whose identity became known to the Employee in connection with the Employee’s relationship with or employment by the Company.
(h)    “Scheduled Settlement Date” shall mean the applicable Vesting Date with respect to a particular tranche of RSUs or as soon as practicable thereafter, but in no event later than March 15 of the calendar year following the calendar year that includes the applicable Vesting Date.
(i)    “Settlement Date” shall mean, with respect to each RSU Share, the date upon which the RSU was settled by the delivery of such RSU Share to the Employee or the date upon which such RSU Share was cancelled in payment of Taxes (as hereinafter defined).
(j)    “RSU Shares” shall mean the number of shares of Common Stock to be delivered upon settlement of the RSUs.

12

Appendix B

		
	1.
	Data Privacy.

(a)    In order to implement, administer, manage and account for the Employee’s participation in the Plan, the Company and/or the Employer may:
(i)    collect and use certain personal data regarding the Employee, including, without limitation, the Employee’s name, home address and telephone number, work address and telephone number, work e-mail address, date of birth, social insurance or other identification number, term of employment, employment status, nationality and tax residence, and details regarding the terms and conditions, grant, vesting, cancellation, termination and expiration of all restricted stock units and other stock based incentives granted, awarded or sold to the Employee by the Company (collectively, the “Data”);
(ii)    transfer the Data, in electronic or other form, to employees of the Company and its subsidiaries, and to third parties, who are involved in the implementation, administration and/or management of, and/or accounting for, the Plan, which recipients may be located in the Employee’s country or in other countries that may have different data privacy laws and protections than the Employee’s country;
(iii)    transfer the Data, in electronic or other form, to a broker or other third party with whom the Employee has elected to deposit any RSU Shares issued in settlement of the RSUs; and
(iv)    retain the Data for only as long as may be necessary in order to implement, administer, manage and account for the Employee’s participation in the Plan.
(b)    The Employee hereby consents to the collection, use, transfer and retention of the Data, as described in this Agreement, for the exclusive purpose of implementing, administering, managing and accounting for the Employee’s participation in the Plan.
(c)    The Employee understands that by contacting his or her local human resources representative, the Employee may:
(i)    view the Data;
(ii)    correct any inaccurate information included within the Data;
(iii)    request additional information regarding the storage and processing of the Data

13

(iv)    request a list with the names and addresses of any potential recipients of the Data; and
(v)    under certain circumstances and with certain consequences, prevent further use, transfer, retention and/or processing of the Data.

14Exhibit
10.1

 

SUBSCRIPTION
AGREEMENT

 

HealthLynked
Corp.

1726
Medical Blvd., Suite 101

Naples, Florida 34110

 

Ladies
and Gentlemen:

 

1.       Subscription. The
undersigned (the “Purchaser”), intending to be legally bound, hereby irrevocably agrees to
purchase from HealthLynked Corp., a Nevada corporation (the “Company”), the number of units (the “Units”) set
forth on the signature page hereof at a purchase price of $3,000 per Unit. Each Unit consists of 60,000 shares of
common stock, par value $0.0001 per share, of the Company (each, a “Share” and collectively, the “Shares”). The
Units are being sold in the Offering (as defined below) as more fully described in the Memorandum (as defined below). This
Subscription Agreement (this “Subscription Agreement”) is one in a series of similar subscription agreements
(collectively, the “Subscription Agreements”) entered into pursuant to the Offering.

 

2.       The
Offering. This subscription is submitted to you in accordance with and subject to the terms and conditions described in this
Subscription Agreement and the Confidential Private Placement Memorandum of the Company dated September 2, 2014, as amended or
supplemented from time to time, including all attachments, schedules and exhibits thereto (the “Memorandum”), relating
to the offering (the “Offering”) by the Company of up to a maximum of 42 Units ($126,000) (“Maximum Offering
Amount”). The terms of the Offering are more completely described in the Memorandum and such terms are incorporated herein
in their entirety.

 

3.       Deliveries
and Payment. Simultaneously with the execution hereof, the Purchaser shall: (a) deliver to the Company, in accordance with
the Subscription Instructions attached hereto, (i) a completed and executed omnibus signature page to this Subscription Agreement
(page 10), (ii) a completed Accredited Investor Certification (pages 13-14), and (b) make a wire transfer payment to, “HealthLynked
Corp.” in the full amount of the purchase price of the Units for which the Purchaser is subscribing in the Offering. Wire
transfer instructions are set forth on page 12 hereof under the heading “To subscribe for Units in the private offering of
HealthLynked Corp.” The funds wired by the Purchaser to the Company will be held by the Company until the earliest to occur
of (a) the closing of this subscription (each closing of a subscription, a “Closing,” and the first of such Closings,
the “First Closing”), (b) the rejection of this subscription by the Company, and (c) the termination of the Offering
by the Company prior to the First Closing. The Company may continue to offer and sell the Units and conduct additional Closings
for the sale of additional Units after the First Closing and until the termination of the Offering.

 

    	 	I-1	 

     

    

 

4.       Acceptance
of Subscription. The Purchaser understands and agrees that the Company, in its sole discretion, reserves the right to accept
or reject this or any other subscription for Units, in whole or in part, notwithstanding prior receipt by the Purchaser of notice
of acceptance of this subscription. The Company shall have no obligation hereunder until the Company executes and delivers to
the Purchaser an executed copy of this Subscription Agreement. If this subscription is rejected in whole or the Offering is terminated,
all funds received from the Purchaser will be returned without interest or offset, and this Subscription Agreement shall thereafter
be of no further force or effect. If this subscription is rejected in part, the funds for the rejected portion of this subscription
will be returned without interest or offset, and this Subscription Agreement will continue in full force and effect to the extent
this subscription was accepted.

 

5.       Representations
and Warranties.

 

The
Purchaser hereby acknowledges, represents, warrants, and agrees as follows:

 

(a)       None
of the Shares are registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state
securities laws. The Purchaser understands that the offering and sale of the Units is intended to be exempt from registration
under the Securities Act, by virtue of Section 4(a)(2) thereof and the provisions of Regulation D (“Regulation D”)
as promulgated by the United States Securities and Exchange Commission (the “SEC”) thereunder, based, in
part, upon the representations, warranties and agreements of the Purchaser contained in this Subscription Agreement;

 

(b)       Prior
to the execution of this Subscription Agreement, the Purchaser and the Purchaser’s attorney, accountant, purchaser representative
and/or tax adviser, if any (collectively, “Advisers”), have received the Memorandum and all other documents requested
by the Purchaser, have carefully reviewed them and understand the information contained therein;

 

(c)       Neither
the SEC nor any state securities commission or other regulatory authority has approved the Units or the Shares, or passed upon
or endorsed the merits of the offering of Units or confirmed the accuracy or determined the adequacy of the Memorandum. The Memorandum
has not been reviewed by any federal, state or other regulatory authority;

 

(d)       All
documents, records, and books pertaining to the investment in the Units (including, without limitation, the Memorandum) have been
made available for inspection by such Purchaser and its Advisers, if any;

 

(e)       The
Purchaser and its Advisers, if any, have had a reasonable opportunity to ask questions of and receive answers from a person or
persons acting on behalf of the Company concerning the Offering and the business, financial condition and results of operations
of the Company, and all such questions have been answered to the full satisfaction of the Purchaser and its Advisers, if any;

 

(f)       In
evaluating the suitability of an investment in the Company, the Purchaser has not relied upon any representation or information
(oral or written) other than as stated in the Memorandum;

 

    	 	I-2	 

     

    

 

(g)       The
Purchaser is unaware of, is in no way relying on, and did not become aware of the Offering through or as a result of, any form
of general solicitation or general advertising including, without limitation, any article, notice, advertisement or other communication
published in any newspaper, magazine or similar media or broadcast over television, radio or the Internet (including, without
limitation, internet “blogs,” bulletin boards, discussion groups and social networking sites) in connection with the
Offering and is not subscribing for the Units and did not become aware of the Offering through or as a result of any seminar or
meeting to which the Purchaser was invited by, or any solicitation of a subscription by, a person not previously known to the
Purchaser in connection with investments in securities generally;

 

(h)       The
Purchaser has taken no action that would give rise to any claim by any person for brokerage commissions, finders’ fees or the
like relating to this Subscription Agreement or the transactions contemplated hereby (other than otherwise described in the Memorandum);

 

(i)       The
Purchaser, together with its Advisers, if any, has such knowledge and experience in financial, tax, and business matters, and,
in particular, investments in securities, so as to enable it to utilize the information made available to it in connection with
the Offering to evaluate the merits and risks of an investment in the Units and the Company and to make an informed investment
decision with respect thereto;

 

0)       The
Purchaser is not relying on the Company or any of their respective employees or agents with respect to the legal, tax, economic
and related considerations of an investment in the Units, and the Purchaser has relied on the advice of, or has consulted with,
only its own Advisers;

 

(k)       The
Purchaser is acquiring the Units solely for such Purchaser’s own account for investment purposes only and not with a view to or
intent of resale or distribution thereof, in whole or in part. The Purchaser has no agreement or arrangement, formal or informal,
with any person to sell or transfer all or any part of the Units or the Shares, and the Purchaser has no plans to enter into any
such agreement or arrangement;

 

(1)       The
Purchaser must bear the substantial economic risks of the investment in the Units indefmitely because none of the securities included
in the Units may be sold, hypothecated or otherwise disposed of unless subsequently registered under the Securities Act and applicable
state securities laws or an exemption from such registration is available. Legends shall be placed on the securities included
in the Units to the effect that they have not been registered under the Securities Act or applicable state securities laws and
appropriate notations thereof will be made in the Company’s books and records. Stop transfer instructions will be placed with
any registrar or transfer agent of the Shares comprising the Units, if other than the Company. There can be no assurance any market
will ever exist for the market for resale of the Shares comprising the Units nor can there be any assurance that such securities
will be freely transferable at any time in the foreseeable future;

 

(m)       The
Purchaser has adequate means of providing for such Purchaser’s current financial needs and foreseeable contingencies and has no
need for liquidity from its investment in the Units for an indefinite period of time;

 

(n)       The
Purchaser is aware that an investment in the Units is high risk, involving a number of very significant risks and has carefully
read and considered the matters set forth under the caption “Risk Factors” in the Memorandum, and, in particular, acknowledges
that the Company has a limited operating history, significant operating losses since inception, limited revenues to date,
limited assets and is engaged in a highly competitive business;

 

    	 	I-3	 

     

    

 

(o)       The
Purchaser meets the requirements of at least one of the suitability standards for an “accredited investor” as that term
is defined in Regulation D and as set forth on the Accredited Investor Certification contained herein;

 

(p)       The
Purchaser (i) if a natural person, represents that the Purchaser has reached the age of 21 and has full power and authority to
execute and deliver this Subscription Agreement and all other related agreements or certificates and to carry out the provisions
hereof and thereof; (ii) if a corporation, partnership, or limited liability company or partnership, or association, joint stock
company, trust, unincorporated organization or other entity, represents that such entity was not formed for the specific purpose
of acquiring the Units, such entity is duly organized, validly existing and in good standing under the laws of the state of its
organization, the consummation of the transactions contemplated hereby is authorized by, and will not result in a violation of
state law or its charter or other organizational documents, such entity has full power and authority to execute and deliver this
Subscription Agreement and all other related agreements or certificates and to carry out the provisions hereof and thereof and
to purchase and hold the securities constituting the Units, the execution and delivery of this Subscription Agreement has been
duly authorized by all necessary action, this Subscription Agreement has been duly executed and delivered on behalf of such entity
and is a legal, valid and binding obligation of such entity; or (iii) if executing this Subscription Agreement in a representative
or fiduciary capacity, represents that it has full power and authority to execute and deliver this Subscription Agreement in such
capacity and on behalf of the subscribing individual, ward, partnership, trust, estate, corporation, or limited liability company
or partnership, or other entity for whom the Purchaser is executing this Subscription Agreement, and such individual, partnership,
ward, trust, estate, corporation, or limited liability company or partnership, or other entity has full right and power to perform
pursuant to this Subscription Agreement and make an investment in the Company, and represents that this Subscription Agreement
constitutes a legal, valid and binding obligation of such entity. The execution and delivery of this Subscription Agreement will
not violate or be in conflict with any order, judgment, injunction, agreement or controlling document to which the Purchaser is
a party or by which it is bound;

 

(q)       The
Purchaser and its Advisers, if any, have had the opportunity to obtain any additional information, to the extent the Company has
such information in its possession or could acquire it without unreasonable effort or expense, necessary to verify the accuracy
of the information contained in the Memorandum and all documents received or reviewed in connection with the purchase of the Units
and have had the opportunity to have representatives of the Company provide them with such additional information regarding the
terms and conditions of this particular investment and the financial condition, results of operations, business of the Company
deemed relevant by the Purchaser or its Advisers, if any, and all such requested information, to the extent the Company had such
information in its possession or could acquire it without unreasonable effort or expense, has been provided to the full satisfaction
of the Purchaser and its Advisers, if any;

 

    	 	I-4	 

     

    

 

(r)       Any
information which the Purchaser has heretofore furnished or is furnishing herewith to the Company is complete and accurate and
may be relied upon by the Company in determining the availability of an exemption from registration under federal and state securities
laws in connection with the offering of securities as described in the Memorandum. The Purchaser further represents and warrants
that it will notify and supply corrective information to the Company immediately upon the occurrence of any change therein occurring
prior to the Company’s issuance of the securities contained in the Units;

 

(s)       The
Purchaser has significant prior investment experience, including investment in non-listed and non-registered securities. The Purchaser
is knowledgeable about investment considerations in development-stage companies with limited operating histories. The Purchaser
has a sufficient net worth to sustain a loss of its entire investment in the Company in the event such a loss should occur. The
Purchaser’s overall commitment to investments which are not readily marketable is not excessive in view of the Purchaser’s net
worth and financial circumstances and the purchase of the Units will not cause such commitment to become excessive. The investment
is a suitable one for the Purchaser;

 

(t)       The
Purchaser is satisfied that the Purchaser has received adequate information with respect to all matters which it or its Advisers,
if any, consider material to its decision to make this investment;

 

(u)       The
Purchaser acknowledges that any estimates or forward-looking statements or projections included in the Memorandum were prepared
by the Company in good faith but that the attainment of any such projections, estimates or forward-looking statements cannot be
guaranteed by the Company and should not be relied upon;

 

(v)       No
oral or written representations have been made, or oral or written information furnished, to the Purchaser or its Advisers, if
any, in connection with the Offering which are in any way inconsistent with the information contained in the Memorandum;

 

(w)       Within
five (5) days after receipt of a request from the Company, the Purchaser will provide such information and deliver such documents
as may reasonably be necessary to comply with any and all laws and ordinances to which the Company is subject;

 

(x)       THE
SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS
AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF SAID ACT AND SUCH LAWS. THE SECURITIES
ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER SAID
ACT AND SUCH LAWS PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE SECURITIES HAVE NOT BEEN RECOMMENDED, APPROVED OR DISAPPROVED
BY THE SECURITIES AND EXCHANGE COMMISSION, ANY STATE SECURITIES COMMISSION OR ANY OTHER REGULATORY AUTHORITY, NOR HAVE ANY OF
THE FOREGOING AUTHORITIES PASSED UPON OR ENDORSED THE MERITS OF THIS OFFERING OR THE ACCURACY OR ADEQUACY OF THE MEMORANDUM OR
THIS SUBSCRIPTION AGREEMENT. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL;

 

    	 	I-5	 

     

    

 

(y)       In
making an investment decision investors must rely on their own examination of the Company and the terms of the Offering, including
the merits and risks involved. The Purchaser is aware that the Purchaser is required to bear the financial risks of this investment
for an indefinite period of time;

 

(z)       (For
ERISA plans only) The fiduciary of the ERISA plan (the “Plan”) represents that such fiduciary has been informed
of and understands the Company’s investment objectives, policies and strategies, and that the decision to invest “plan assets”
(as such term is defined in ERISA) in the Company is consistent with the provisions of ERISA that require diversification of plan
assets and impose other fiduciary responsibilities. The Purchaser fiduciary or Plan (a) is responsible for the decision to invest
in the Company; (b) is independent of the Company or any of its affiliates; (c) is qualified to make such investment decision;
and (d) in making such decision, the Purchaser fiduciary or Plan has not relied primarily on any advice or recommendation of the
Company or any of its affiliates;

 

(aa)
The Purchaser should check the Office of Foreign Assets Control (“OFAC”) website at <http://www.treas.gov/ofac>
before making the following representations. The Purchaser represents that the amounts invested by it in the Company in the
Offering were not and are not directly or indirectly derived from activities that contravene federal, state or international laws
and regulations, including anti-money laundering laws and regulations. Federal regulations and Executive Orders administered by
OFAC prohibit, among other things, the engagement in transactions with, and the provision of services to, certain foreign countries,
territories, entities and individuals. The lists of OFAC prohibited countries, territories, persons and entities can be found
on the OFAC website at <http://www.treas.gov/ofac>. In addition, the programs administered by OFAC (the “OFAC Programs”)
prohibit dealing with individuals1 or entities in certain countries regardless of whether such individuals or entities
appear on the OFAC lists;

 

(bb)  
To the best of the Purchaser’s knowledge, none of: (1) the Purchaser; (2) any person controlling or controlled by the Purchaser;
(3) if the Purchaser is a privately-held entity, any person having a beneficial interest in the Purchaser; or (4) any person for
whom the Purchaser is acting as agent or nominee in connection with this investment is a country, territory, individual or entity
named on an OFAC list, or a person or entity prohibited under the OFAC Programs. The Purchaser understands and acknowledges that
the Company may not accept any amounts from a prospective investor if such prospective investor cannot make the representation
set forth in the preceding paragraph. The Purchaser agrees to promptly notify the Company if the Purchaser becomes aware of any
change in the information set forth in these representations. The Purchaser understands and acknowledges that, by law, the Company
may be obligated to “freeze the account” of the Purchaser, either by prohibiting additional subscriptions from the Purchaser,
declining any redemption requests and/or segregating the assets in the account in compliance with governmental regulations. The
Purchaser further acknowledges that the Company may, by written notice to the Purchaser, suspend the redemption rights, if any,
of the Purchaser if the Company reasonably deems it necessary to do so to comply with anti-money laundering regulations applicable
to the Company or any of the Company’s other service providers. These individuals include specially designated nationals, specially
designated narcotics traffickers and other parties subject to OFAC sanctions and embargo programs;

 

 

1
These individuals include specially designated nationals, specially designated narcotics traffickers and other parties subject
to OFAC sanctions and embargo programs.

 

    	 	I-6	 

     

    

 

(cc)
   To the best of the Purchaser’s knowledge, none of (1) the Purchaser; (2) any person controlling or controlled by the Purchaser;
(3) if the Purchaser is a privately-held entity, any person having a beneficial interest in the Purchaser; or (4) any person for
whom the Purchaser is acting as agent or nominee in connection with this investment is a senior foreign political figure2
or any immediate family3 member or close associate4 of a senior foreign political figure, as such
terms are defined in the footnotes below; and

 

(dd)
  If the Purchaser is affiliated with a non-U.S. banking institution (a “Foreign Bank”), or if the Purchaser receives
deposits from, makes payments on behalf of, or handles other financial transactions related to a Foreign Bank, the Purchaser represents
and warrants to the Company that: (1) the Foreign Bank has a fixed address, other than solely an electronic address, in a country
in which the Foreign Bank is authorized to conduct banking activities; (2) the Foreign Bank maintains operating records related
to its banking activities; (3) the Foreign Bank is subject to inspection by the banking authority that licensed the Foreign Bank
to conduct banking activities; and (4) the Foreign Bank does not provide banking services to any other Foreign Bank that does
not have a physical presence in any country and that is not a regulated affiliate.

 

6.       Indemnification.
The Purchaser agrees to indemnify and hold harmless the Company, and its officers, directors, employees, agents, control persons
and affiliates from and against all losses, liabilities, claims, damages, costs, fees and expenses whatsoever (including, but
not limited to, any and all expenses incurred in investigating, preparing or defending against any litigation commenced or threatened)
based upon or arising out of any actual or alleged false acknowledgment, representation or warranty, or misrepresentation or omission
to state a material fact, or breach by the Purchaser of any covenant or agreement made by the Purchaser herein or in any other
document delivered in connection with this Subscription Agreement.

 

7.       Irrevocability;
Binding Effect. The Purchaser hereby acknowledges and agrees that the subscription hereunder is irrevocable by the Purchaser,
except as required by applicable law, and that this Subscription Agreement shall survive the death or disability of the Purchaser
and shall be binding upon and inure to the benefit of the parties and their heirs, executors, administrators, successors, legal
representatives, and permitted assigns. If the Purchaser is more than one person, the obligations of the Purchaser hereunder shall
be joint and several and the agreements, representations, warranties, and acknowledgments herein shall be deemed to be made by
and be binding upon each such person and such person’s heirs, executors, administrators, successors, legal representatives, and
permitted assigns.

 

 

2
A “senior foreign political figure” is defined as a senior official in the executive, legislative, administrative,
military or judicial branches of a foreign government (whether elected or not), a senior official of a major foreign political
party, or a senior executive of a foreign government-owned corporation. In addition, a “senior foreign political figure”
includes any corporation, business or other entity that has been formed by, or for the benefit of, a senior foreign political
figure.

 

3
“Immediate family” of a senior foreign political figure typically includes the figure’s parents, siblings, spouse,
children and in-laws.

 

4
A “close associate” of a senior foreign political figure is a person who is widely and publicly known to maintain
an unusually close relationship with the senior foreign political figure, and includes a person who is in a position to conduct
substantial domestic and international financial transactions on behalf of the senior foreign political figure.

 

    	 	I-7	 

     

    

 

8.       Modification.
This Subscription Agreement shall not be modified or waived except by an instrument in writing signed by the party against
whom any such modification or waiver is sought.

 

9.       Notices.
Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be deemed effectively
given: (a) upon personal delivery to the party notified, (b) when sent by confirmed email or facsimile if sent during normal business
hours of the recipient, if not, then on the next business day, (c) five days after having been sent by registered or certified
mail, return receipt requested, postage prepaid, or (d) one day after deposit with a nationally recognized overnight courier,
specifying next day delivery, with written verification of receipt. All communications shall be sent to the parties at their respective
address, email or facsimile number set forth on the signature page hereto, or to such other address as such party shall have furnished
in writing in accordance with the provisions of this Section 9.

 

10.       Assignability.
This Subscription Agreement and the rights, interests and obligations hereunder are not transferable or assignable by the
Purchaser and the transfer or assignment of the Shares shall be made only in accordance with all applicable laws.

 

11.       Applicable
Law. This Subscription Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable
to contracts to be wholly-performed within said State.

 

12.       Blue
Sky Qualification. The purchase of Units under this Subscription Agreement is expressly conditioned upon the exemption from
qualification of the offer and sale of the Units from applicable federal and state securities laws. The Company shall not be required
to qualify this transaction under the securities laws of any jurisdiction and, should qualification be necessary, the Company
shall be released from any and all obligations to maintain its offer, and may rescind any sale contracted, in the jurisdiction.

 

13.       Use
of Pronouns. All pronouns and any variations thereof used herein shall be deemed to refer to the masculine, feminine, neuter,
singular or plural as the identity of the person or persons referred to may require.

 

14.       Confidentiality.
The Purchaser acknowledges and agrees that any information or data the Purchaser has acquired from or about the Company, not
otherwise properly in the public domain, was received in confidence. The Purchaser agrees not to divulge, communicate or disclose,
except as may be required by law or for the performance of this Subscription Agreement, or use, or misuse in any way, any confidential
information of the Company, including any scientific, technical, trade or business secrets of the Company and any scientific,
technical, trade or business materials that are treated by the Company as confidential or proprietary, including, but not limited
to, ideas, discoveries, inventions, developments and improvements belonging to the Company and confidential information obtained
by or given to the Company about or belonging to third parties.

 

    	 	I-8	 

     

    

 

15.       Miscellaneous.

 

(a)       This
Subscription Agreement, including all attachments, schedules and exhibits thereto, constitutes the entire agreement between the
Purchaser and the Company with respect to the subject matter hereof and supersede all prior oral or written agreements and understandings,
if any, relating to the subject matter hereof.

 

(b)       The
representations and warranties of the Purchaser made in this Subscription Agreement shall survive the execution and delivery hereof
and delivery of the Shares comprising the Units.

 

(c)       Each
of the parties hereto shall pay its own fees and expenses (including the fees of any attorneys, accountants, appraisers or others
engaged by such party) in connection with this Subscription Agreement and the transactions contemplated hereby whether or not
the transactions contemplated hereby are consummated.

 

(d)       This
Subscription Agreement may be executed in one or more counterparts each of which shall be deemed an original, but all of which
shall together constitute one and the same instrument.

 

(e)       Each
provision of this Subscription Agreement shall be considered separable and, if for any reason any provision or provisions hereof
are determined to be invalid or contrary to applicable law, such invalidity or illegality shall not impair the operation of or
affect the remaining portions of this Subscription Agreement.

 

(f)       Paragraph
and Section titles are for convenience and descriptive purposes only and are not to be considered in construing or interpreting
this Subscription Agreement.

 

(g)       The
Purchaser understands and acknowledges that there may be multiple closings for this Offering.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]

 

    	 	I-9	 

     

    

 

HEALTHLYNKED
CORP.

OMNIBUS
SIGNATURE PAGE TO THE SUBSCRIPTION AGREEMENT

 

Purchaser
hereby elects to subscribe under the Subscription Agreement for a total of ______________ Units at a price of $3,000 per Unit,
and, by execution and delivery hereof (return two (2) originals), Purchaser hereby executes the Subscription Agreement and agrees
to be bound by the terms and conditions of the Subscription Agreement.

 

Date:
______________________________________________

 

If
the Purchaser is an INDIVIDUAL, and if purchased as JOINT TENANTS, as TENANTS IN COMMON, or as COMMUNITY PROPERTY:

 

	 	 	 
	Print
    Name(s)	 	Social
    Security Number(s)
	 	 	 
	 	 	 
	Signature(s)
    of Purchaser(s)	 	Signature
	 	 	 
	 	 	 
	Date	 	Address
	 	 	 
	 	 	 
	Fax
    Number	 	Email
    Address

 

If
the Purchaser is a PARTNERSHIP, CORPORATION, LIMITED LIABILITY COMPANY or TRUST:

 

	 	 	 
	Name
    of Entity	 	Federal
    Tax Identification Number
	 	 	 	 
	By:	 	 	
	 	Name:
    	 	State
of Organization
	 	Title:	 	 
	 	 	 	 
	 	 	 
	Date
    	 	Address
	 	 	 
	 	 	 
	Fax
    Number	 	Email
    Address

 

    	 	I-10	 

     

    

 

	Accepted:	 
	HEALTHLYNKED
    CORP.	 
	 	 
	By:	 	 
	 	Authorized
    Officer	 
	 	 	 
	 	 
	Address	 
	 	 
	 	 
	Fax
    Number	 
	 	 
	 	 
	Email
    Address	 

 

    	 	I-11	 

     

    

 

PRIVATE
PLACEMENT OFFERING OF 

HEALTHLYNKED CORP.

 

SUBSCRIPTION
INSTRUCTIONS 

 

To
subscribe for Units in the private offering of HealthLynked Corp.

 

	1.	Date and Fill in the number of Units being purchased
and Complete and Sign two (2) copies of the Omnibus Signature Page to the Subscription Agreement (page 10).

 

	2.	Initial the Accredited Investor Certification
page attached to the Subscription Agreement (pages 13-14).

 

	3.	E-mail all forms to Dr. Michael Dent at mdentl@comcast.net
and then send all signed original documents to:

 

Dr.
Michael Dent HealthLynked Corp.

1726
Medical Blvd Suite 101

Naples,
Florida 34110

 

	5.	Please wire funds directly to HealthLynked Corp.
pursuant to the following instructions (unless other arrangements have been made):

 

Wells
Fargo Bank, N.A.

Routing
Number: 063107513

Account
Number: 7092859870

 

    	 	I-12	 

     

    

 

HEALTHLYNKED
CORP.

 

ACCREDITED
INVESTOR CERTIFICATION

 

For
Individual Investors Only

(all
Individual Investors must INITIAL where appropriate):

 

	Initial
    ______________	I
have an individual net worth, or joint net worth with my spouse, as of the date hereof in excess of $1 million. For purposes of
calculating net worth under this category, (i) the undersigned’s primary residence shall not be included as an asset, (ii) indebtedness
that is secured by the undersigned’s primary residence, up to the estimated fair market value of the primary residence at the
time of the sale of securities, shall not be included as a liability, (iii) to the extent that the indebtedness that is secured
by the primary residence is in excess of the fair market value of the primary residence, the excess amount shall be included as
a liability, and (iv) if the amount of outstanding indebtedness that is secured by the primary residence exceeds the amount outstanding
60 days prior to the execution of this Subscription Agreement, other than as a result of the acquisition of the primary residence,
the amount of such excess shall be included as a liability.
	 	 
	Initial
    ______________	I
have had an annual gross income for the past two years of at least $200,000 (or $300,000 jointly with my spouse) and expect my
income (or joint income, as appropriate) to reach the same level in the current year.
	 	 
	Initial
    ______________	I
am a director or executive officer of HealthLynked Corp. (the “Company”)

 

For
Non-Individual Investors

(all
Non-Individual Investors must INITIAL where appropriate):

 

	Initial
    ______________	The
investor certifies that it is a partnership, corporation, limited liability company or business trust that is 100% owned by persons
who meet at least one of the criteria for Individual Investors set forth above.
	 	 
	Initial
    ______________	The
investor certifies that it is a partnership, corporation, limited liability company or any organization described in Section 501(c)(3)
of the Internal Revenue Code, Massachusetts or similar business trust that has total assets of at least $5 million and was not
formed for the purpose of investing the Company.
	 	 
	Initial
    ______________	The
investor certifies that it is an employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974,
whose investment decision is made by a plan fiduciary (as defined in ERISA §3(21)) that is a bank, savings and loan association,
insurance company or registered investment adviser.

 

    	 	I-13	 

     

    

 

	Initial
    ______________	The
investor certifies that it is an employee benefit plan whose total assets exceed $5,000,000 as of the date of this certification.
	 	 
	Initial
    ______________	The
    undersigned certifies that it is a self-directed employee benefit plan whose investment decisions are made solely by persons
    who meet either of the criteria for Individual Investors.
	 	 
	Initial
    ______________	The
investor certifies that it is a U.S. bank, U.S. savings and loan association or other similar U.S. institution acting in its individual
or fiduciary capacity.
	 	 
	Initial
    ______________	The
undersigned certifies that it is a broker-dealer registered pursuant to §15 of the Securities Exchange Act of 1934, as amended.
	 	 
	Initial
    ______________	The
investor certifies that it is an organization described in §501(c)(3) of the Internal Revenue Code with total assets exceeding
$5,000,000 and not formed for the specific purpose of investing in the Company.
	 	 
	Initial
    ______________	The
investor certifies that it is a trust with total assets of at least $5,000,000, not formed for the specific purpose of investing
in the Company, and whose purchase is directed by a person with such knowledge and experience in financial and business matters
that he is capable of evaluating the merits and risks of the prospective investment.
	 	 
	Initial
    ______________	The
    investor certifies that it is a plan established and maintained by a state or its political subdivisions, or any agency or
    instrumentality thereof, for the benefit of its employees, and which has total assets in excess of $5,000,000.
	 	 
	Initial
    ______________	The
investor certifies that it is an insurance company as defined in §2(13) of the Securities Act, or a registered investment
company.
	 	 
	Initial
    ______________	The
    investor certifies that it is an investment company registered under the Investment Company Act of 1940, as amended, or a
    business development company as defined in Section 2(a)(48) of that Act.
	 	 
	Initial
    ______________	The
    investor certifies that it is a Small Business Investment Company licensed by the U.S. Small Business Administration under
    Section 301(c) or (d) of the Small Business Investment Act of 1958, as amended.
	 	 
	Initial
    ______________	The
investor certifies that it is a private business development company as defined in Section 202(a)(22) of the Investment Advisers
Act of 1940, as amended.

 

    	 	I-14	 

     

    

 

 

SUBSCRIPTION
AGREEMENT

 

HealthLynked
Corp.

1726
Medical Blvd., Suite 101

Naples,
Florida 34110

 

Ladies
and Gentlemen:

 

1.       Subscription.
The undersigned (the “Purchaser”), intending to be legally bound, hereby irrevocably agrees to purchase from
HealthLynked Corp., a Nevada corporation (the “Company”), the number of units (the “Units”) set
forth on the signature page hereof at a purchase price of $3,000 per Unit. Each Unit consists of 60,000 shares of common stock,
par value $0.0001 per share, of the Company (each, a “Share” and collectively, the “Shares”). The Units are
being sold in the Offering (as defined below) as more fully described in the Memorandum (as defined below). This Subscription
Agreement (this “Subscription Agreement”) is one in a series of similar subscription agreements (collectively,
the “Subscription Agreements”) entered into pursuant to the Offering.

 

2.       The
Offering. This subscription is submitted to you in accordance with and subject to the terms and conditions described in this
Subscription Agreement and the Confidential Private Placement Memorandum of the Company dated September 30, 2015, as amended or
supplemented from time to time, including all attachments, schedules and exhibits thereto (the “Memorandum”), relating
to the offering (the “Offering”) by the Company of up to a maximum of 50 Units ($150,000) (the “Maximum
Offering Amount”), subject to an increase of the Maximum Offering Amount by an additional 10 Units ($50,000). The terms
of the Offering are more completely described in the Memorandum and such terms are incorporated herein in their entirety.

 

3.       Deliveries
and Payment. Simultaneously with the execution hereof, the Purchaser shall: (a) deliver to the Company, in accordance with
the Subscription Instructions attached hereto, (i) a completed and executed omnibus signature page to this Subscription Agreement
(page 15), (ii) a completed Accredited Investor Certification (pages 18-19) and (iii) a completed Selling Stockholder Questionnaire
(pages 20-24); and (b) make a wire transfer payment to, “HealthLynked Corp.” in the full amount of the purchase price
of the Units for which the Purchaser is subscribing in the Offering. Wire transfer instructions are set forth on page 17 hereof
under the heading “To subscribe for Units in the private offering of HealthLynked Corp.” The funds wired by the Purchaser
to the Company will be held by the Company until the earliest to occur of (a) the closing of this subscription (each closing of
a subscription, a “Closing,” and the first of such Closings, the “First Closing”), (b) the rejection
of this subscription by the Company, and (c) the termination of the Offering by the Company prior to the First Closing. The Company
may continue to offer and sell the Units and conduct additional Closings for the sale of additional Units after the First Closing
and until the earlier of (x) the termination of the Offering by the Company and (y) the receipt of the Company of gross proceeds
in the Offering totaling the Maximum Offering Amount (as it may be increased pursuant to Section 2). For the avoidance of doubt,
the Company shall be entitled to reject this subscription or terminate the Offering at any time in its absolute and sole discretion.

 

    	 	II-1	 

     

    

 

4.       Acceptance
of Subscription. The Purchaser understands and agrees that the Company, in its sole discretion, reserves the right to accept
or reject this or any other subscription for Units, in whole or in part, notwithstanding prior receipt by the Purchaser of notice
of acceptance of this subscription. The Company shall have no obligation hereunder until the Company executes and delivers to
the Purchaser an executed copy of this Subscription Agreement. If this subscription is rejected in whole or the Offering is terminated,
all funds received from the Purchaser will be returned without interest or offset, and this Subscription Agreement shall thereafter
be of no further force or effect. If this subscription is rejected in part, the funds for the rejected portion of this subscription
will be returned without interest or offset, and this Subscription Agreement will continue in full force and effect to the extent
this subscription was accepted.

 

5.       Representations
and Warranties.

 

The
Purchaser hereby acknowledges, represents, warrants, and agrees as follows:

 

(a)       None
of the Shares are registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state
securities laws. The Purchaser understands that the offering and sale of the Units is intended to be exempt from registration
under the Securities Act, by virtue of Section 4(a)(2) thereof and the provisions of Regulation D (“Regulation D”)
as promulgated by the United States Securities
and Exchange Commission (the “SEC”) thereunder, based, in part, upon the representations, warranties and agreements
of the Purchaser contained in this Subscription Agreement;

 

(b)       Prior
to the execution of this Subscription Agreement, the Purchaser and the Purchaser’s attorney, accountant, purchaser representative
and/or tax adviser, if any (collectively, “Advisers”), have received the Memorandum and all other documents requested
by the Purchaser, have carefully reviewed them and understand the information contained therein;

 

(c)       Neither
the SEC nor any state securities commission or other regulatory authority has approved the Units or the Shares, or passed upon
or endorsed the merits of the offering of Units or confirmed the accuracy or determined the adequacy of the Memorandum. The Memorandum
has not been reviewed by any federal, state or other regulatory authority;

 

(d)       All
documents, records, and books pertaining to the investment in the Units (including, without limitation, the Memorandum) have been
made available for inspection by such Purchaser and its Advisers, if any;

 

(e)       The
Purchaser and its Advisers, if any, have had a reasonable opportunity to ask questions of and receive answers from a person or
persons acting on behalf of the Company concerning the Offering and the business, financial condition and results of operations
of the Company, and all such questions have been answered to the full satisfaction of the Purchaser and its Advisers, if any;

 

    	 	II-2	 

     

    

 

(f)       In
evaluating the suitability of an investment in the Company, the Purchaser has not relied upon any representation or information
(oral or written) other than as stated in the Memorandum;

 

(g)       The
Purchaser is unaware of, is in no way relying on, and did not become aware of the Offering through or as a result of, any form
of general solicitation or general advertising including, without limitation, any article, notice, advertisement or other communication
published in any newspaper, magazine or similar media or broadcast over television, radio or the Internet (including, without
limitation, interne “blogs,” bulletin boards, discussion groups and social networking sites) in connection with the
Offering and is not subscribing for the Units and did not become aware of the Offering through or as a result of any seminar or
meeting to which the Purchaser was invited by, or any solicitation of a subscription by, a person not previously known to the
Purchaser in connection with investments in securities generally;

 

(h)       The
Purchaser has taken no action that would give rise to any claim by any person for brokerage commissions, finders’ fees or the
like relating to this Subscription Agreement or the transactions contemplated hereby (other than otherwise described in the Memorandum);

 

(i)       The
Purchaser, together with its Advisers, if any, has such knowledge and experience in financial, tax, and business matters, and,
in particular, investments in securities, so as to enable it to utilize the information made available to it in connection with
the Offering to evaluate the merits and risks of an investment in the Units and the Company and to make an informed investment
decision with respect thereto;

 

0)       The
Purchaser is not relying on the Company or any of their respective employees

 

or
agents with respect to the legal, tax, economic and related considerations of an investment in the Units, and the Purchaser has
relied on the advice of, or has consulted with, only its own Advisers;

 

(k)       The
Purchaser is acquiring the Units solely for such Purchaser’s own account for

 

investment
purposes only and not with a view to or intent of resale or distribution thereof, in whole or in part. The Purchaser has no agreement
or arrangement, formal or informal, with any person to sell or transfer all or any part of the Units or the Shares, and the Purchaser
has no plans to enter into any such agreement or arrangement;

 

(1)       The
Purchaser must bear the substantial economic risks of the investment in the

 

Units
indefmitely because none of the securities included in the Units may be sold, hypothecated or otherwise disposed of unless subsequently
registered under the Securities Act and applicable state securities laws or an exemption from such registration is available.
Legends shall be placed on the securities included in the Units to the effect that they have not been registered under the Securities
Act or applicable state securities laws and appropriate notations thereof will be made in the Company’s books and records. Stop
transfer instructions will be placed with any registrar or transfer agent of the Shares comprising the Units, if other than the
Company. There can be no assurance any market will ever exist for the market for resale of the Shares comprising the Units nor
can there be any assurance that such securities will be freely transferable at any time in the foreseeable future;

 

    	 	II-3	 

     

    

 

(m)
The Purchaser has adequate means of providing for such Purchaser’s current financial needs and foreseeable contingencies and has
no need for liquidity from its investment in the Units for an indefinite period of time;

 

(n)       The
Purchaser is aware that an investment in the Units is high risk, involving a number of very significant risks and has carefully
read and considered the matters set forth under the caption “Risk Factors” in the Memorandum, and, in particular, acknowledges
that the Company has a limited operating history, significant operating losses since inception, limited revenues to date, limited
assets and is engaged in a highly competitive business;

 

(o)       The
Purchaser meets the requirements of at least one of the suitability standards for an “accredited investor” as that term
is defined in Regulation D and as set forth on the Accredited Investor Certification contained herein;

 

(p)       The
Purchaser (i) if a natural person, represents that the Purchaser has reached the age of 21 and has full power and authority
to execute and deliver this Subscription Agreement and all other related agreements or certificates and to carry out the
provisions hereof and thereof;

 

(ii)       if
a corporation, partnership, or limited liability company or partnership, or association, joint stock company, trust, unincorporated
organization or other entity, represents that such entity was not formed for the specific purpose of acquiring the Units, such
entity is duly organized, validly existing and in good standing under the laws of the state of its organization, the consummation
of the transactions contemplated hereby is authorized by, and will not result in a violation of state law or its charter or other
organizational documents, such entity has full power and authority to execute and deliver this Subscription Agreement and all
other related agreements or certificates and to carry out the provisions hereof and thereof and to purchase and hold the securities
constituting the Units, the execution and delivery of this Subscription Agreement has been duly authorized by all necessary action,
this Subscription Agreement has been duly executed and delivered on behalf of such entity and is a legal, valid and binding obligation
of such entity; or

 

(iii)       if
executing this Subscription Agreement in a representative or fiduciary capacity, represents that it has full power and authority
to execute and deliver this Subscription Agreement in such capacity and on behalf of the subscribing individual, ward, partnership,
trust, estate, corporation, or limited liability company or partnership, or other entity for whom the Purchaser is executing this
Subscription Agreement, and such individual, partnership, ward, trust, estate, corporation, or limited liability company or partnership,
or other entity has full right and power to perform pursuant to this Subscription Agreement and make an investment in the Company,
and represents that this Subscription Agreement constitutes a legal, valid and binding obligation of such entity. The execution
and delivery of this Subscription Agreement will not violate or be in conflict with any order, judgment, injunction, agreement
or controlling document to which the Purchaser is a party or by which it is bound;

 

(q)       The
Purchaser and its Advisers, if any, have had the opportunity to obtain any additional information, to the extent the Company has
such information in its possession or could acquire it without unreasonable effort or expense, necessary to verify the accuracy
of the information contained in the Memorandum and all documents received or reviewed in connection with the purchase of the Units
and have had the opportunity to have representatives of the Company provide them with such additional information regarding the
terms and conditions of this particular investment and the financial condition, results of operations, business of the Company
deemed relevant by the Purchaser or its Advisers, if any, and all such requested information, to the extent the Company had such
information in its possession or could acquire it without unreasonable effort or expense, has been provided to the full satisfaction
of the Purchaser and its Advisers, if any;

 

    	 	II-4	 

     

    

 

(r)       Any
information which the Purchaser has heretofore furnished or is furnishing herewith to the Company is complete and accurate and
may be relied upon by the Company in determining the availability of an exemption from registration under federal and state securities
laws in connection with the offering of securities as described in the Memorandum. The Purchaser further represents and warrants
that it will notify and supply corrective information to the Company immediately upon the occurrence of any change therein occurring
prior to the Company’s issuance of the securities contained in the Units;

 

(s)       The
Purchaser has significant prior investment experience, including investment in non-listed and non-registered securities. The Purchaser
is knowledgeable about investment considerations in development-stage companies with limited operating histories. The Purchaser
has a sufficient net worth to sustain a loss of its entire investment in the Company in the event such a loss should occur. The
Purchaser’s overall commitment to investments which are not readily marketable is not excessive in view of the Purchaser’s net
worth and financial circumstances and the purchase of the Units will not cause such commitment to become excessive. The investment
is a suitable one for the Purchaser;

 

(t)       The
Purchaser is satisfied that the Purchaser has received adequate information with respect to all matters which it or its Advisers,
if any, consider material to its decision to make this investment;

 

(u)       The
Purchaser acknowledges that any estimates or forward-looking statements or projections included in the Memorandum were prepared
by the Company in good faith but that the attainment of any such projections, estimates or forward-looking statements cannot be
guaranteed by the Company and should not be relied upon;

 

(v)       No
oral or written representations have been made, or oral or written information furnished, to the Purchaser or its Advisers, if
any, in connection with the Offering which are in any way inconsistent with the information contained in the Memorandum;

 

(w)       Within
five (5) days after receipt of a request from the Company, the Purchaser will provide such information and deliver such documents
as may reasonably be necessary to comply with any and all laws and ordinances to which the Company is subject;

 

(x)       THE
SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS
AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF SAID ACT AND SUCH LAWS. THE SECURITIES
ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER SAID
ACT AND SUCH LAWS PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE SECURITIES HAVE NOT BEEN RECOMMENDED, APPROVED OR DISAPPROVED
BY THE SECURITIES AND EXCHANGE COMMISSION, ANY STATE SECURITIES COMMISSION OR ANY OTHER REGULATORY AUTHORITY, NOR HAVE ANY OF
THE FOREGOING AUTHORITIES PASSED UPON OR ENDORSED THE MERITS OF THIS OFFERING OR THE ACCURACY OR ADEQUACY OF THE MEMORANDUM OR
THIS SUBSCRIPTION AGREEMENT. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL;

 

    	 	II-5	 

     

    

 

y)       In
making an investment decision investors must rely on their own examination of the Company and the terms of the Offering, including
the merits and risks involved. The Purchaser is aware that the Purchaser is required to bear the financial risks of this investment
for an indefinite period of time;

 

z)       (For
ERISA plans only) The fiduciary of the ERISA plan (the “Plan”) represents that such fiduciary has been informed
of and understands the Company’s investment objectives, policies and strategies, and that the decision to invest “plan assets”
(as such term is defined in ERISA) in the Company is consistent with the provisions of ERISA that require diversification of plan
assets and impose other fiduciary responsibilities. The Purchaser fiduciary or Plan (a) is responsible for the decision to invest
in the Company; (b) is independent of the Company or any of its affiliates; (c) is qualified to make such investment decision;
and (d) in making such decision, the Purchaser fiduciary or Plan has not relied primarily on any advice or recommendation of the
Company or any of its affiliates;

 

aa)     The
Purchaser should check the Office of Foreign Assets Control (“OFAC”) website at <http://www.treas.gov/ofac>
before making the following representations. The Purchaser represents that the amounts invested by it in the Company in the
Offering were not and are not directly or indirectly derived from activities that contravene federal, state or international laws
and regulations, including anti-money laundering laws and regulations. Federal regulations and Executive Orders administered by
OFAC prohibit, among other things, the engagement in transactions with, and the provision of services to, certain foreign countries,
territories, entities and individuals. The lists of OFAC prohibited countries, territories, persons and entities can be found
on the OFAC website at <http://www.treas.gov/ofac>. In addition, the programs administered by OFAC (the “OFAC
Programs”) prohibit dealing with individuals1 or entities in certain countries regardless of whether such
individuals or entities appear on the OFAC lists;

 

bb)     To
the best of the Purchaser’s knowledge, none of: (1) the Purchaser; (2) any person controlling or controlled by the Purchaser;
(3) if the Purchaser is a privately-held entity, any person having a beneficial interest in the Purchaser; or (4) any person for
whom the Purchaser is acting as agent or nominee in connection with this investment is a country, territory, individual or entity
named on an OFAC list, or a person or entity prohibited under the OFAC Programs. The Purchaser understands and acknowledges that
the Company may not accept any amounts from a prospective investor if such prospective investor cannot make the representation
set forth in the preceding paragraph. The Purchaser agrees to promptly notify the Company if the Purchaser becomes aware of any
change in the information set forth in these representations. The Purchaser understands and acknowledges that, by law, the Company
may be obligated to “freeze the account” of the Purchaser, either by prohibiting additional subscriptions from the Purchaser,
declining any redemption requests and/or segregating the assets in the account in compliance with governmental regulations. The
Purchaser further acknowledges that the Company may, by written notice to the Purchaser, suspend the redemption rights, if any,
of the Purchaser if the Company reasonably deems it necessary to do so to comply with anti-money laundering regulations applicable
to the Company or any of the Company’s other service providers. These individuals include specially designated nationals, specially
designated narcotics traffickers and other parties subject to OFAC sanctions and embargo programs;

 

 

1
These individuals include specially designated nationals, specially designated narcotics traffickers and other parties subject
to OFAC sanctions and embargo programs.

 

    	 	II-6	 

     

    

 

cc)     To
the best of the Purchaser’s knowledge, none of: (1) the Purchaser; (2) any person controlling or controlled by the Purchaser;
(3) if the Purchaser is a privately-held entity, any person having a beneficial interest in the Purchaser; or (4) any person for
whom the Purchaser is acting as agent or nominee in connection with this investment is a senior foreign political figure,2
or any immediate family3 member or close associate4 of a senior foreign political figure, as such
terms are defined in the footnotes below; and

 

dd)     If
the Purchaser is affiliated with a non-U.S. banking institution (a “Foreign Bank”), or if the Purchaser receives
deposits from, makes payments on behalf of, or handles other financial transactions related to a Foreign Bank, the Purchaser represents
and warrants to the Company that: (1) the Foreign Bank has a fixed address, other than solely an electronic address, in a country
in which the Foreign Bank is authorized to conduct banking activities; (2) the Foreign Bank maintains operating records related
to its banking activities; (3) the Foreign Bank is subject to inspection by the banking authority that licensed the Foreign Bank
to conduct banking activities; and (4) the Foreign Bank does not provide banking services to any other Foreign Bank that does
not have a physical presence in any country and that is not a regulated affiliate.

 

6.       Registration
Rights.

 

(a)       Definitions.
As used in Section 6, Section 7 and Section 8 of this Subscription Agreement, the following terms shall have the meanings
set forth below:

 

(i)       “Filing
Date” means the date that is one hundred and twenty (120) days after the Final Closing Date.

 

 

2
A “senior foreign political figure” is defined as a senior official in the executive, legislative, administrative,
military or judicial branches of a foreign government (whether elected or not), a senior official of a major foreign political
party, or a senior executive of a foreign government-owned corporation. In addition, a “senior foreign political figure”
includes any corporation, business or other entity that has been formed by, or for the benefit of, a senior foreign political
figure.

 

3
“Immediate family” of a senior foreign political figure typically includes the figure’s parents, siblings, spouse,
children and in-laws.

 

4
A “close associate” of a senior foreign political figure is a person who is widely and publicly known to maintain
an unusually close relationship with the senior foreign political figure, and includes a person who is in a position to conduct
substantial domestic and international financial transactions on behalf of the senior foreign political figure.

 

    	 	II-7	 

     

    

 

(ii)       “Final
Closing Date” means such date on which the last Closing occurs and after which the Company ceases to offer any Units
for sale in this Offering.

 

(iii)      The
terms “register,” “registered” and “registration” refer to a registration effected
by preparing and filing with the SEC a registration statement or similar document in compliance with the Securities Act, and the
declaration or ordering of effectiveness by the SEC of such registration statement or document.

 

(iv)       “Registrable
Securities” means all shares of Common Stock underlying the Units and any securities issued or then issuable upon any
stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing; provided, however,
that none of the foregoing shall be Registrable Securities if the holder thereof has not completed and delivered to the Company
a Selling Stockholder Questionnaire in the form attached to this Subscription Agreement; provided further, that any such Registrable
Securities shall cease to be Registrable Securities (i) upon any sale pursuant to the Registration Statement (as defined below)
or Rule 144 promulgated under the Securities Act, (ii) at such time such securities become eligible for resale without volume
or manner-of- sale restrictions pursuant to Rule 144, provided that at such time the Company is also in compliance with current
public information requirements, or (iii) upon becoming Remainder Shares.

 

(v)       “Rule
144” means Rule 144 as promulgated by the SEC under the Securities Act, as such rule may be amended from time to time,
or any similar successor rule that may be promulgated by the SEC.

 

(vi)      “Rule
415” means Rule 415 as promulgated by the SEC under the Securities Act, as such rule may be amended from time to time,
or any similar successor rule that may be promulgated by the SEC.

 

(vii)     “SEC
Guidance” means (i) any written or oral guidance, comments, interpretations, requirements or requests of the SEC staff
and (ii) the Securities Act and the rules and regulations promulgated thereunder.

 

(b)       Company
Registration.

 

(i)       On
or prior to the Filing Date, the Company shall prepare and file with the SEC one (1) registration statement (the “Registration
Statement”) covering the resale of the Registrable Securities in an offering to be made on a continuous basis pursuant
to Rule 415. The Registration Statement shall be on Form S-1 or, if the Company is so eligible, on Form S-3. The Company shall
use its commercially reasonable efforts to cause the Registration Statement to be declared effective under the Securities Act
as soon as reasonably possible. The Company shall use its commercially reasonable efforts to keep the Registration Statement continuously
effective under the Securities Act until all Registrable Securities covered by the Registration Statement have been sold, or may
be sold without the requirement to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant
to Rule 144, as determined by the counsel to the Company (the “Effectiveness Period”).

 

    	 	II-8	 

     

    

 

(ii)       If
the Registration Statement is not filed on or prior to the Filing Date (unless the reason for such non-registration of all or
any portion of the Registrable Securities is as a result of SEC Guidance under Rule 415 or similar rule which limits the number
of Registrable Securities which may be included in a registration statement with respect to the Purchaser) (any such failure to
file being referred to as an “Event”, and the date on which such Event occurs being referred to as an “Event Date”),
then as the exclusive remedy of Purchaser, on each thirty (30) day anniversary of the Event Date (if the Event shall not have
been cured by such date) until the Event is cured, the Company shall pay to the Purchaser an amount in cash, as partial liquidated
damages and not as a penalty, equal to one percent (1%) of the aggregate purchase price paid by the Purchaser pursuant to this
Subscription Agreement for such failure to file such number of securities as shall not have been included in the Registration
Statement on the Filing Date. The partial liquidated damages pursuant to the terms hereof shall apply on a daily pro rata basis
for any portion of a thirty (30) day period prior to the cure of an Event. Notwithstanding the foregoing, no payments shall be
owed with respect to any period during which all of the Purchaser’s Registrable Securities may be sold by such Purchaser under
Rule 144 without volume or manner-of-sale restrictions pursuant to Rule 144.

 

(iii)       Notwithstanding
the registration obligations set forth herein, in the event the SEC informs the Company that the Registrable Securities sought
to be registered by the Registration Statement cannot, as a result of the application of Rule 415 or similar rule or SEC Guidance
related thereto, be registered for resale as a secondary offering on a single registration statement, the Company shall promptly
inform the Purchaser thereof and shall use its commercially reasonable efforts to file an amendment to the Registration Statement
so that it covers the maximum number of Registrable Securities permitted by the SEC Guidance to be registered for resale as a
secondary offering on a single registration statement. Notwithstanding anything to the contrary in this Subscription Agreement,
(a) if any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered by the Registration
Statement, the number of Registrable Securities to be registered by the Registration Statement shall be reduced among all selling
stockholders named therein pro rata based on the number of Registrable Securities then held by each such selling stockholder,
unless a selling stockholder directs the Company in writing to register fewer of its Registrable Securities and subject to a determination
by the SEC that the Registrable Securities held by certain selling stockholder(s) must be reduced first, and (b) in the event
the Company amends, in accordance with this Section 6(b)(iii), the Registration Statement, the Company shall have no obligation
to file with the SEC any additional registration statement(s) to register for resale any of the shares of Common Stock Underlying
the Units that were not registered on the Registration Statement, as so amended (all such unregistered shares of Common Stock,
the “Remainder Shares”).

 

(iv)       The
Company shall bear and pay all expenses incurred in connection with any registration, filing or qualification of Registrable Securities
with respect to the registration required pursuant to this Section 6 for the Purchaser, including (without limitation) all registration,
filing and qualification fees, printer’s fees, accounting fees and fees and disbursements of counsel for the Company, but excluding
any brokerage or underwriting fees, discounts and commissions relating to Registrable Securities and fees and disbursements of
counsel for the Purchaser.

 

    	 	II-9	 

     

    

 

(c)       Obligations
of the Company. During the Effectiveness Period, the Company shall, as expeditiously as reasonably possible:

 

(i)       Furnish
to the Purchaser such numbers of copies of the prospectus, including any preliminary prospectus, contained in the Registration
Statement and filed in conformity with the requirements of the Securities Act, and such other documents as it may reasonably request
in order to facilitate the disposition of its Registrable Securities registered therein (provided that the Company shall not be
required to print or furnish such prospectuses if readily available to the Purchaser from any electronic service, such as on the
EDGAR filing database maintained at www.sec.gov);

 

(ii)       Use
its commercially reasonable efforts to register or qualify, unless an exemption from such registration or qualification is available,
the Registrable Securities covered by the Registration Statement under such other securities’ or blue sky laws of such jurisdictions
within the United States as shall be reasonably requested in writing by the Purchaser; provided that the Company shall not be
required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of
process in any such states or jurisdictions;

 

(iii)       Notify
the Purchaser, with respect to a prospectus relating to the Registrable Securities held by such Purchaser, within one business
day (i) after the effectiveness of the Registration Statement that includes such prospectus, or (ii) after the happening of any
event as a result of which the prospectus included in the Registration Statement, as then in effect, includes an untrue statement
of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein
not misleading in the light of the circumstances then existing; and

 

(iv)       Cause
all Registrable Securities registered pursuant hereto to be listed or quoted on each securities exchange or nationally recognized
quotation system on which similar securities issued by the Company are then listed or quoted.

 

7.       Obligations
of the Purchasers.

 

(a)       On
or prior to the Closing of the Purchaser’s subscription hereunder and on an annual basis thereafter as the Company may request
in connection with the preparation and filing of amendments to the Registration Statement, the Purchaser shall deliver to the
Company a completed Selling Stockholder Questionnaire It shall be a condition precedent to the obligations of the Company that
such Purchaser shall furnish to the Company such information regarding itself, the Registrable Securities held by it and the intended
method of disposition of the Registrable Securities held by it as shall be reasonably required to timely effect such registration
of such Registrable Securities and shall execute such documents in connection with such registration as the Company may reasonably
request.

 

(b)       The
Purchaser, by such Purchaser’s acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested
by the Company in connection with the preparation and filing of the Registration Statement hereunder, unless such Purchaser has
notified the Company in writing of such Purchaser’s election to exclude all of such Purchaser’s Registrable Securities from the
Registration Statement.

 

    	 	II-10	 

     

    

 

(c)       Notwithstanding
anything to the contrary in this Subscription Agreement, at any time after the Registration Statement has been declared effective,
the Company may delay the disclosure of material non-public information concerning the Company, the disclosure of which at the
time is not, in the good faith opinion of the Board of Directors of the Company, in the best interest of the Company (the period
of such delay, a “Grace Period”), and during such Grace Period, after receipt of the notice described below,
the Purchaser shall not sell any Registrable Securities or any other securities of the Company that are held by such Purchaser
and shall not disclose to any third party that such a notice has been given or the contents of the notice; provided, that the
Company shall promptly (i) notify the Purchasers in writing of the existence of material non-public information giving rise to
a Grace Period (provided that in such notice the Company shall not disclose the contents of such material non-public information
to the Purchasers) and the date on which the Grace Period will begin, and (ii) notify the Purchasers in writing of the date on
which the Grace Period will end; and, provided further, that during any consecutive 365-day period, there shall be only three
(3) Grace Periods and any such Grace Period shall not exceed forty five (45) days (each, an “Allowable Grace Period”).
For purposes of determining the length of a Grace Period, a Grace Period shall begin on and include the date the Purchaser
receives the notice referred to in clause (i) above and shall end on and include the later of the date the Purchaser receives
the notice referred to in clause (ii) above and the date referred to in such notice.

 

(d)       Each
Purchaser agrees that, upon receipt of any notice from the Company (i) of the issuance of a stop order or other suspension of
effectiveness of the Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale
in any jurisdiction, (ii) of the happening of any event or the passage of time as a result of which the financial statements included
in the Registration Statement, as then in effect, are ineligible for inclusion therein or the prospectus included in the Registration
Statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be
stated therein or necessary to make the statements therein (in the case of any preliminary prospectus or final prospectus or amendments
or supplements thereto included in the Registration Statement, in light of the circumstances under which they were made) not misleading,
or (iii) pursuant to Section 7(c), such Purchaser will immediately discontinue disposition of all Registrable Securities pursuant
to the Registration Statement until, upon the occurrence of an event described in Sections 7(d)(i) or (ii), such Purchaser’s receipt
of the copies of, or notice of the filing on the EDGAR filing database maintained at www.sec.gov of, a supplement or amendment
to the Registration Statement and the prospectus included therein to correct such untrue statement or omission or update such
financial statements, or, upon the occurrence of an event described in Section 7(d)(iii), until the end of the applicable Grace
Period as specified in Section 7(c), and, if so directed by the Company, such Purchaser shall deliver to the Company (at the expense
of the Company) or destroy all copies of any prospectus covering such Registrable Securities in such Purchaser’s possession at
the time of the occurrence of any such event.

 

    	 	II-11	 

     

    

 

(e)       Each
Purchaser will comply with the prospectus delivery requirements of the Securities Act as applicable to it in connection with any
sales of Registrable Securities pursuant to the Registration Statement.

 

8.       Indemnification.

 

(a)       The
Purchaser agrees to indemnify and hold harmless the Company, and its officers, directors, employees, agents, control persons and
affiliates from and against all losses, liabilities, claims, damages, costs, fees and expenses whatsoever (including, but not
limited to, any and all expenses incurred in investigating, preparing or defending against any litigation commenced or threatened)
based upon or arising out of any actual or alleged false acknowledgment, representation or warranty, or misrepresentation or omission
to state a material fact, or breach by the Purchaser of any covenant or agreement made by the Purchaser herein or in any other
document delivered in connection with this Subscription Agreement.

 

(b)       The
Purchaser agrees to indemnify and hold harmless the Company and its officers, directors, employees, agents, control persons and
affiliates from and against all losses, liabilities, claims, damages, costs, fees and expenses whatsoever (including, but not
limited to, any and all expenses incurred in investigating, preparing or defending against any litigation commenced or threatened)
based upon or arising out of any untrue statement or alleged untrue statement of a material fact contained in the Registration
Statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto,
or omission to state a material fact required to be stated therein or necessary to make the statements therein (in the case of
any preliminary prospectus or final prospectus or amendments or supplements thereto, in light of the circumstances under which
they were made) not misleading, in each case to the extent (and only to the extent) that such losses, liabilities, claims, damages,
costs, fees and expenses arise out of (i) reliance upon and in conformity with written information furnished by the Purchaser
expressly for use in connection with such registration, including without limitation the information included in the Purchaser’s
Selling Stockholder Questionnaires delivered hereunder; provided, however, in no event shall any indemnity under this Section
8(b) exceed the net proceeds received by such Purchaser upon the sale of the Registrable Securities giving rise to such indemnification
obligation.

 

(c)       The
Company agrees to indemnify and hold harmless the Purchaser and its officers, directors, employees, agents, control persons and
affiliates from and against all losses, liabilities, claims, damages, costs, fees and expenses whatsoever (including, but not
limited to, any and all expenses incurred in investigating, preparing or defending against any litigation commenced or threatened)
based upon or arising out of any untrue statement or alleged untrue statement of a material fact contained in the Registration
Statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto,
or omission to state a material fact required to be stated therein or necessary to make the statements therein (in the case of
any preliminary prospectus or final prospectus or amendments or supplements thereto, in light of the circumstances under which
they were made) not misleading; provided, however, in no event shall the Company be liable under this Section 8(c) for any losses,
liabilities, claims, damages, costs, fees and expenses to the extent that such losses, liabilities, claims, damages, costs, fees
and expenses arise out of (i) reliance upon and in conformity with written information furnished expressly for use in connection
with such registration by the Purchaser or (ii) any of the circumstances set forth in Sections 8(b)(i), (ii) or (iii).

 

    	 	II-12	 

     

    

 

9.       Irrevocability;
Binding Effect. The Purchaser hereby acknowledges and agrees that the subscription hereunder is irrevocable by the Purchaser,
except as required by applicable law, and that this Subscription Agreement shall survive the death or disability of the Purchaser
and shall be binding upon and inure to the benefit of the parties and their heirs, executors, administrators, successors, legal
representatives, and permitted assigns. If the Purchaser is more than one person, the obligations of the Purchaser hereunder shall
be joint and several and the agreements, representations, warranties, and acknowledgments herein shall be deemed to be made by
and be binding upon each such person and such person’s heirs, executors, administrators, successors, legal representatives,
and permitted assigns.

 

10.     Modification.
This Subscription Agreement shall not be modified or waived except by an instrument in writing signed by the party against
whom any such modification or waiver is sought.

 

11.     Notices.
Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be deemed effectively
given: (a) upon personal delivery to the party notified, (b) when sent by confirmed email or facsimile if sent during normal business
hours of the recipient, if not, then on the next business day, (c) five days after having been sent by registered or certified
mail, return receipt requested, postage prepaid, or (d) one day after deposit with a nationally recognized overnight courier,
specifying next day delivery, with written verification of receipt. All communications shall be sent to the parties at their respective
address, email or facsimile number set forth on the signature page hereto, or to such other address as such party shall have furnished
in writing in accordance with the provisions of this Section 11.

 

12.     Assignability.
This Subscription Agreement and the rights, interests and obligations hereunder are not transferable or assignable by the
Purchaser and the transfer or assignment of the Shares shall be made only in accordance with all applicable laws.

 

13.     Applicable
Law. This Subscription Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable
to contracts to be wholly-performed within said State.

 

14.     Blue
Sky Qualification. The purchase of Units under this Subscription Agreement is expressly conditioned upon the exemption from
qualification of the offer and sale of the Units from applicable federal and state securities laws. The Company shall not be required
to qualify this transaction under the securities laws of any jurisdiction and, should qualification be necessary, the Company
shall be released from any and all obligations to maintain its offer, and may rescind any sale contracted, in the jurisdiction.

 

15.     Use
of Pronouns. All pronouns and any variations thereof used herein shall be deemed to refer to the masculine, feminine, neuter,
singular or plural as the identity of the person or persons referred to may require.

 

    	 	II-13	 

     

    

 

16.      Confidentiality.
The Purchaser acknowledges and agrees that any information or data the Purchaser has acquired from or about the Company, not
otherwise properly in the public domain, was received in confidence. The Purchaser agrees not to divulge, communicate or disclose,
except as may be required by law or for the performance of this Subscription Agreement, or use, or misuse in any way, any confidential
information of the Company, including any scientific, technical, trade or business secrets of the Company and any scientific,
technical, trade or business materials that are treated by the Company as confidential or proprietary, including, but not limited
to, ideas, discoveries, inventions, developments and improvements belonging to the Company and confidential information obtained
by or given to the Company about or belonging to third parties.

 

17.      Miscellaneous.

 

(a)       This
Subscription Agreement, including all attachments, schedules and exhibits thereto, constitutes the entire agreement between the
Purchaser and the Company with respect to the subject matter hereof and supersede all prior oral or written agreements and understandings,
if any, relating to the subject matter hereof.

 

(b)       The
representations and warranties of the Purchaser made in this Subscription Agreement shall survive the execution and delivery hereof
and delivery of the Shares underlying the Units.

 

(c)       Each
of the parties hereto shall pay its own fees and expenses (including the fees of any attorneys, accountants, appraisers or others
engaged by such party) in connection with this Subscription Agreement and the transactions contemplated hereby whether or not
the transactions contemplated hereby are consummated.

 

(d)       This
Subscription Agreement may be executed in one or more counterparts each of which shall be deemed an original, but all of which
shall together constitute one and the same instrument.

 

(e)       Each
provision of this Subscription Agreement shall be considered separable and, if for any reason any provision or provisions hereof
are determined to be invalid or contrary to applicable law, such invalidity or illegality shall not impair the operation of or
affect the remaining portions of this Subscription Agreement.

 

(f)       Paragraph
and Section titles are for convenience and descriptive purposes only and are not to be considered in construing or interpreting
this Subscription Agreement.

 

(g)       The
Purchaser understands and acknowledges that there may be multiple closings for this Offering.

 

18.      Lockup.
The Purchaser shall enter into and abide by the terms of a lockup agreement substantially in the form attached as Annex B
to the Memorandum.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]

 

    	 	II-14	 

     

    

 

HEALTHLYNKED
CORP.

OMNIBUS
SIGNATURE PAGE TO THE SUBSCRIPTION AGREEMENT

 

Purchaser
hereby elects to subscribe under the Subscription Agreement for a total of ________________ Units at a price of $3,000 per Unit,
and, by execution and delivery hereof (return two (2) originals), Purchaser hereby executes the Subscription Agreement and agrees
to be bound by the terms and conditions of the Subscription Agreement.

 

Date:
__________________________________________________

 

If
the Purchaser is an INDIVIDUAL, and if purchased as JOINT TENANTS, as TENANTS IN COMMON, or as COMMUNITY PROPERTY:

 

	 	 	 
	Print
    Name(s)	 	Social
    Security Number(s)
	 	 	 
	 	 	 
	Signature(s)
    of Purchaser(s)	 	Signature
	 	 	 
	 	 	 
	Date	 	Address
	 	 	 
	 	 	 
	Fax
    Number	 	Email
    Address

 

If
the Purchaser is a PARTNERSHIP, CORPORATION, LIMITED LIABILITY COMPANY or TRUST:

 

	 	 	 
	Name
    of Entity	 	Federal
    Tax Identification Number
	 	 	 	 
	By:	 	 	 
	 	Name:
    	 	State
    of Organization
	 	Title:	 	 
	 	 	 	 
	 	 	 
	Date
    	 	Address
	 	 	 
	 	 	 
	Fax
    Number	 	Email
    Address

 

    	 	II-15	 

     

    

 

	Accepted:	 
	HEALTHLYNKED
    CORP.	 
	 	 
	By:	 	 
	 	Authorized
    Officer	 
	 	 	 
	 	 
	Address	 
	 	 
	 	 
	Fax
    Number	 
	 	 
	 	 
	Email
    Address	 

 

    	 	II-16	 

     

    

 

PRIVATE
PLACEMENT OFFERING OF 

HEALTHLYNKED CORP.

 

SUBSCRIPTION
INSTRUCTIONS 

 

To
subscribe for Units in the private offering of HealthLynked Corp.

 

		1.	Date
                                         and Fill in the number of Units being purchased and Complete and Sign two
                                         (2) copies of the Omnibus Signature Page to the Subscription Agreement (page 15).

 

		2.	Initial
                                         the Accredited Investor Certification page attached to the Subscription Agreement
                                         (pages 18-19).

 

		3.	E-mail
                                         all forms to Dr. Michael Dent at mdentl @comcast.net or George O’Leary at goleary@sksconsulting.us
                                         and then send all signed original documents to:

 

Dr.
Michael Dent HealthLynked Corp.

1726
Medical Blvd Suite 101

Naples,
Florida 34110

 

	5.	Please wire funds directly to HealthLynked Corp.
pursuant to the following instructions (unless other arrangements have been made):

 

Wells
Fargo Bank, N.A.

420 Montgomery

San
Francisco CA 94104

Routing Number: 121000248

 

HealthLynked
Corporation

1726 Medical Blvd Suite 101

Naples FL 34110

Account
Number: 7092859870

 

    	 	II-17	 

     

    

 

HEALTHLYNKED
CORP.

ACCREDITED
INVESTOR CERTIFICATION

 

For
Individual Investors Only

(all
Individual Investors must INITIAL where appropriate):

 

	Initial
    _______________	I
    have an individual net worth, or joint net worth with my spouse, as of the date hereof in excess of $1 million. For purposes
    of calculating net worth under this category, (i) the undersigned’s primary residence shall not be included as an asset, (ii)
    indebtedness that is secured by the undersigned’s primary residence, up to the estimated fair market value of the primary
    residence at the time of the sale of securities, shall not be included as a liability, (iii) to the extent that the indebtedness
    that is secured by the primary residence is in excess of the fair market value of the primary residence, the excess amount
    shall be included as a liability, and (iv) if the amount of outstanding indebtedness that is secured by the primary residence
    exceeds the amount outstanding 60 days prior to the execution of this Subscription Agreement, other than as a result of the
    acquisition of the primary residence, the amount of such excess shall be included as a liability.
	 	 
	Initial
    _______________	I
    have had an annual gross income for the past two years of at least $200,000 (or $300,000 jointly with my spouse) and expect
    my income (or joint income, as appropriate) to reach the same level in the current year.
	 	 
	Initial
    _______________	I
am a director or executive officer of HealthLynked Corp. (the “Company”)

 

For
Non-Individual Investors

(all
Non-Individual Investors must INITIAL where appropriate):

 

	Initial
    _______________ 	The
    investor certifies that it is a partnership, corporation, limited liability company or business trust that is 100% owned by
    persons who meet at least one of the criteria for Individual Investors set forth above.
	 	 
	Initial
    _______________ 	The
    investor certifies that it is a partnership, corporation, limited liability company or any organization described in Section
    501(c)(3) of the Internal Revenue Code, Massachusetts or similar business trust that has total assets of at least $5 million
    and was not formed for the purpose of investing the Company.
	 	 
	Initial
    _______________ 	The
    investor certifies that it is an employee benefit plan within the meaning of the Employee Retirement Income Security Act of
    1974, whose investment decision is made by a plan fiduciary (as defined in ERISA §3(21)) that is a bank, savings and
    loan association, insurance company or registered investment adviser.

 

    	 	II-18	 

     

    

 

	Initial
    _______________ 	The
investor certifies that it is an employee benefit plan whose total assets exceed $5,000,000 as of the date of this certification.
	 	 
	Initial
    _______________ 	The
undersigned certifies that it is a self-directed employee benefit plan whose investment decisions are made solely by persons who
meet either of the criteria for Individual Investors.
	 	 
	Initial
    _______________ 	The
    investor certifies that it is a U.S. bank, U.S. savings and loan association or other similar U.S. institution acting in its
    individual or fiduciary capacity.
	 	 
	Initial
    _______________ 	The
    undersigned certifies that it is a broker-dealer registered pursuant to §15 of the Securities Exchange Act of 1934, as
    amended.
	 	 
	Initial
    _______________ 	The
investor certifies that it is an organization described in §501(c)(3) of the Internal Revenue Code with total assets exceeding
$5,000,000 and not formed for the specific purpose of investing in the Company.
	 	 
	Initial
    _______________ 	The
    investor certifies that it is a trust with total assets of at least $5,000,000, not formed for the specific purpose of investing
    in the Company, and whose purchase is directed by a person with such knowledge and experience in financial and business matters
    that he is capable of evaluating the merits and risks of the prospective investment.
	 	 
	Initial
    _______________ 	The
    investor certifies that it is a plan established and maintained by a state or its political subdivisions, or any agency or
    instrumentality thereof, for the benefit of its employees, and which has total assets in excess of $5,000,000.
	 	 
	Initial
    _______________ 	The
    investor certifies that it is an insurance company as defined in §2(13) of the Securities Act, or a registered investment
    company.
	 	 
	Initial
    _______________ 	The
    investor certifies that it is an investment company registered under the Investment Company Act of 1940, as amended, or a
    business development company as defined in Section 2(a)(48) of that Act.
	 	 
	Initial
    _______________ 	The
    investor certifies that it is a Small Business Investment Company licensed by the U.S. Small Business Administration under
    Section 301(c) or (d) of the Small Business Investment Act of 1958, as amended.
	 	 
	Initial
    _______________ 	The
    investor certifies that it is a private business development company as defined in Section 202(a)(22) of the Investment Advisers
    Act of 1940, as amended.

 

    	 	II-19	 

     

    

 

SELLING
STOCKHOLDER QUESTIONNAIRE

 

The
undersigned holder of shares of the common stock of HealthLynked Corp., a Nevada corporation (the “Company”), issued
pursuant to the Subscription Agreement by and between the Company and the undersigned (the “Agreement”) (all
or a portion of such shares, the “Registrable Securities”), understands that the Company intends to file with
the Securities and Exchange Commission (the “SEC”) one or more registration statements (each, a “Registration
Statement”) for the registration and the resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities
Act”), of the Registrable Securities in accordance with the terms of the Agreement. All capitalized terms not otherwise
defined herein shall have the meanings given to them in the Agreement.

 

In
order to sell or otherwise dispose of any Registrable Securities pursuant to a Registration Statement, a holder of Registrable
Securities generally will be required to be named as a selling stockholder in the related prospectus or a supplement thereto (as
so supplemented, the “Prospectus”), deliver the Prospectus to purchasers of Registrable Securities (including
pursuant to Rule 172 under the Securities Act) and be bound by the provisions of the Agreement (including certain indemnification
provisions). Holders must also complete and deliver this Selling Stockholder Questionnaire in order to be named as selling stockholders
in the Prospectus. Holders of Registrable Securities who do not complete, execute and return this Selling Stockholder Questionnaire
on or before the date(s) specified in the Agreement (1) will not be named as selling stockholders in a Registration Statement
or the Prospectus and (2) may not use the Prospectus for re-sales of Registrable Securities.

 

Certain
legal consequences arise from being named as a selling stockholder in a Registration Statement and the Prospectus. Holders of
Registrable Securities are advised to consult their own counsel regarding the consequences of being named or not named as a selling
stockholder in a Registration Statement and the Prospectus.

 

1.       Name.

 

		(a)	Full
                                         Legal Name of the Selling Stockholder:

 

 

 

 

 

		(b)	Full
                                         Legal Name of Registered Holder (if not the same as (a) above) through which Registrable
                                         Securities listed in Item 3 below are held:

 

 

 

 

 

 

 

 

 

    	 	II-20	 

     

    

 

	 	(c)	If the Selling Stockholder is not a Natural Person,
the Full Legal Name of the Natural Control Persons (which means the natural person(s) who directly or indirectly, alone or with
others, has the power to vote or dispose of the securities covered by this Selling Stockholder Questionnaire):

 

 

 

 

 

 

 

	2.	Contact Information for Notices to Selling Stockholder
relating to the Registration Statement.

 

Contact
Person: ___________________________________________________________________________________

 

Fax
No. for Contact Person: __________________________________________________________________________

 

Email
address of Contact Person: ______________________________________________________________________

 

	3.	Beneficial Ownership of Registrable Securities.

 

		(a)	Type
                                         and Number of Registrable Securities beneficially owned and issued pursuant to the Agreement:

 

 

 

 

 

 

 

 

 

		(b)	Number
                                         of shares of Registrable Securities listed in Item 3(a) that the Selling Stockholder
                                         requests be registered for resale pursuant to a Registration Statement:

 

 

 

 

 

 

 

 

 

	4.	Broker-Dealer Status of Affiliation.

 

	 	(a)	Are you a broker-dealer?

 

	 	Yes

    _______________________	No

    _______________________

 

    	 	II-21	 

     

    

 

		(b)	If
                                         “yes” to Section 4(a), did you receive your Registrable Securities as compensation
                                         for investment banking services to the Company?

 

	 	Yes
    _______________________	No
    _______________________

 

Note:
If no, the SEC’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

	(c)	Are you an affiliate of a broker-dealer?

 

	’	Yes
    _______________________	No _______________________

 

If
yes, provide a narrative explanation below:

 

		(c)	If
                                         you are an affiliate of a broker-dealer, do you certify that you bought the Registrable
                                         Securities in the ordinary course of business, and at the time of the purchase of the
                                         Registrable Securities to be resold, you had no agreements or understandings, directly
                                         or indirectly, with any person to distribute the Registrable Securities?

 

	 	Yes_______________________	No
    _______________________

 

Note:
If no, the SEC’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

	5.	Beneficial Ownership of Other Securities of the Company
Owned by the Selling Stockholder.

 

Except
as set forth below in this Item 5, the undersigned is not the beneficial or registered owner of any securities of the Company
other than the Registrable Securities listed above in Item 3.

 

	 	(a)	Type and amount of other securities of the Company beneficially
owned (if none, so state):

 

 

 

 

 

 

 

 

 

    	 	II-22	 

     

    

 

	6.	Relationships with the Company.

 

Except
as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners
of 5% of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship
with the Company (or its predecessors or affiliates) during the past three years.

 

State
any exceptions here:

 

 

 

 

 

 

 

*
* *

 

The
undersigned agrees to promptly notify the Company of any inaccuracies or changes in the

 

information
provided herein that may occur subsequent to the date hereof and prior to the effective date of the Registration Statement and
at any time while the Registration Statement remains effective. All notices by the undersigned hereunder and pursuant to the Agreement
shall be made in writing and delivered as set forth in the Agreement. In the absence of any such notification, the Company shall
be entitled to rely and continue to rely on the accuracy of the information in this Selling Stockholder Questionnaire.

 

The
undersigned also acknowledges that the answers to Items (1) through (6) in this Selling Stockholder Questionnaire are furnished
for use in connection with a Registration Statement to be filed pursuant to the Agreement and any amendments or supplements thereto
filed with the SEC pursuant to the Securities Act. By signing below, the undersigned consents to the disclosure of its answers
to Items (1) through (6) and the inclusion of such information in any Registration Statement and any Prospectus. The undersigned
understands that such information will be relied upon by the Company in connection with the preparation or amendment of any such
Registration Statement and any such Prospectus.

 

By
signing below, the undersigned acknowledges that it understands its obligation to comply, and agrees that it will comply, with
the provisions of the Exchange Act of 1934, as amended, and the rules and regulations thereunder, particularly Regulation M in
connection with any offering of Registrable Securities pursuant to a Registration Statement.

 

The
undersigned hereby acknowledges and is advised of the following Division of Corporation Financing Compliance and Disclosure Interpretation
239.10 regarding short selling:

 

“An
issuer filed a Form S-1 registration statement for a secondary offering of common stock which is not yet effective. One of the
selling shareholders wanted to do a short sale of common stock “against the box” and cover the short sale with registered
shares after the effective date. The issuer was advised that the short sale could not be made before the registration statement
becomes effective, because the shares underlying the short sale are deemed to be sold at the time such sale is made. There would,
therefore, be a violation of Section 5 if the shares were effectively sold prior to the effective date.”

 

By
completing, signing and returning this Selling Stockholder Questionnaire, the undersigned will be deemed to be aware of the foregoing
interpretation. The acknowledgements by and agreements of the undersigned set forth in this Selling Stockholder Questionnaire
shall be in addition to, and shall not limit the scope and applicability of, the representations, warranties and covenants made
by the undersigned in the Agreement.

 

    	 	II-23	 

     

    

 

The
undersigned represents, warrants and certifies that, to the best of its knowledge and belief, the foregoing statements (including
without limitation the answers to Items (1) through (6) in this Selling Stockholder Questionnaire) are correct and complete.

 

*
* *

 

IN
WITNESS WHEREOF the undersigned, by authority duly given, has caused this Selling Stockholder Questionnaire to be executed
and delivered either in person or by its duly authorized agent.

 

	 	 	 	Selling
    Stockholder:
	 	 	 	 	 
	Dated: 	 	 	By:	 
	 	 	 	Name:	 
	 	 	 	Title:	 

	                    	                     	Email
    Address:	                     

 

PLEASE
RETURN THE COMPLETED AND EXECUTED SELLING STOCKHOLDER

QUESTIONNAIRE IN ACCORDANCE WITH THE INSTRUCTIONS
SET FORTH IN THE

“SUBSCRIPTION INSTRUCTIONS” ATTACHED TO
THE AGREEMENT.

 

    	 	II-24	 

     

    

 

 

SUBSCRIPTION
AGREEMENT

 

HealthLynked
Corp.

1726
Medical Blvd., Suite 101

Naples,
Florida 34110

 

Ladies
and Gentlemen:

 

1.       Subscription.
The undersigned (the “Purchaser”), intending to be legally bound, hereby irrevocably agrees to purchase from
HealthLynked Corp., a Nevada corporation (the “Company”), the number of units (the “Units”) set
forth on the signature page hereof at a purchase price of $5,000 per Unit. Each Unit consists of 62,500 shares of common stock
at $0.08 per share, par value $0.0001 per share, of the Company (each, a “Share” and collectively, the “Shares”).
The Units are being sold in the Offering (as defined below) as more fully described in the Memorandum (as defined below).
This Subscription Agreement (this “Subscription Agreement”) is one in a series of similar subscription agreements
(collectively, the “Subscription Agreements”) entered into pursuant to the Offering. Purchaser will be entitled
to receive 100% warrant coverage at 125% of the stock purchase price or $0.10 per warrant share as documented in a separate warrant
agreement (“Warrant Agreement”).

 

2.       The
Offering. This subscription is submitted to you in accordance with and subject to the terms and conditions described in this
Subscription Agreement and the Confidential Private Placement Memorandum of the Company dated September 30, 2015, as amended or
supplemented from time to time, including all attachments, schedules and exhibits thereto (the “Memorandum”), relating
to the offering (the “Offering”) by the Company of up to a maximum of 50 Units ($250,000) (the “Maximum
Offering Amount”), subject to an increase of the Maximum Offering Amount by an additional 10 Units ($50,000). The terms
of the Offering are more completely described in the Memorandum and such terms are incorporated herein in their entirety.

 

3.       Deliveries
and Payment. Simultaneously with the execution hereof, the Purchaser shall: (a) deliver to the Company, in accordance with
the Subscription Instructions attached hereto, (i) a completed and executed omnibus signature page to this Subscription Agreement
(page 15), (ii) a completed Accredited Investor Certification (pages 18-19) and (iii) a completed Selling Stockholder Questionnaire
(pages 20-24); and (b) make a wire transfer payment to, “HealthLynked Corp.” in the full amount of the purchase price
of the Units for which the Purchaser is subscribing in the Offering. Wire transfer instructions are set forth on page 17 hereof
under the heading “To subscribe for Units in the private offering of HealthLynked Corp.” The funds wired by the Purchaser
to the Company will be held by the Company until the earliest to occur of (a) the closing of this subscription (each closing of
a subscription, a “Closing,” and the first of such Closings, the “First Closing”), (b) the rejection
of this subscription by the Company, and (c) the termination ofthe Offering by the Company prior to the First Closing. The Company
may continue to offer and sell the Units and conduct additional Closings for the sale of additional Units after the First Closing
and until the earlier of (x) the termination of the Offering by the Company and (y) the receipt of the Company of gross proceeds
in the Offering totaling the Maximum Offering Amount (as it may be increased pursuant to Section 2). For the avoidance of doubt,
the Company shall be entitled to reject this subscription or terminate the Offering at any time in its absolute and sole discretion.

 

    	 	III-1	 

     

    

 

4.       Acceptance
of Subscription. The Purchaser understands and agrees that the Company, in its sole discretion, reserves the right to accept
or reject this or any other subscription for Units, in whole or in part, notwithstanding prior receipt by the Purchaser of notice
of acceptance of this subscription. The Company shall have no obligation hereunder until the Company executes and delivers to
the Purchaser an executed copy of this Subscription Agreement. If this subscription is rejected in whole or the Offering is terminated,
all funds received from the Purchaser will be returned without interest or offset, and this Subscription Agreement shall thereafter
be of no further force or effect. If this subscription is rejected in part, the funds for the rejected portion of this subscription
will be returned without interest or offset, and this Subscription Agreement will continue in full force and effect to the extent
this subscription was accepted.

 

5.       Representations
and Warranties.

 

The
Purchaser hereby acknowledges, represents, warrants, and agrees as follows:

 

(a)       None
of the Shares are registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state
securities laws. The Purchaser understands that the offering and sale of the Units is intended to be exempt from registration
under the Securities Act, by virtue of Section 4(a)(2) thereof and the provisions of Regulation
D (“Regulation D”)
as promulgated by the United States Securities and Exchange Commission (the “SEC”) thereunder, based, in part, upon
the representations, warranties and agreements of the Purchaser contained in this Subscription Agreement;

 

(b)       Prior
to the execution of this Subscription Agreement, the Purchaser and the Purchaser’s attorney, accountant, purchaser representative
and/or tax adviser, if any (collectively, “Advisers”), have received the Memorandum and all other documents requested
by the Purchaser, have carefully reviewed them and understand the information contained therein;

 

(c)       Neither
the SEC nor any state securities commission or other regulatory authority has approved the Units or the Shares, or passed upon
or endorsed the merits of the offering of Units or confirmed the accuracy or determined the adequacy of the Memorandum. The Memorandum
has not been reviewed by any federal, state or other regulatory authority;

 

(d)       All
documents, records, and books pertaining to the investment in the Units (including, without limitation, the Memorandum) have been
made available for inspection by such Purchaser and its Advisers, if any;

 

(e)       The
Purchaser and its Advisers, if any, have had a reasonable opportunity to ask questions of and receive answers from a person or
persons acting on behalf of the Company concerning the Offering and the business, financial condition and results of operations
of the Company, and all such questions have been answered to the full satisfaction of the Purchaser and its Advisers, if any;

 

    	 	III-2	 

     

    

 

(f)       In
evaluating the suitability of an investment in the Company, the Purchaser has not relied upon any representation or information
(oral or written) other than as stated in the Memorandum;

 

(g)       The
Purchaser is unaware of, is in no way relying on, and did not become aware of the Offering through or as a result of, any form
of general solicitation or general advertising including, without limitation, any article, notice, advertisement or other communication
published in any newspaper, magazine or similar media or broadcast over television, radio or the Internet (including, without
limitation, internet “blogs,” bulletin boards, discussion groups and social networking sites) in connection with the
Offering and is not subscribing for the Units and did not become aware of the Offering through or as a result of any seminar or
meeting to which the Purchaser was invited by, or any solicitation of a subscription by, a person not previously known to the
Purchaser in connection with investments in securities generally;

 

(h)       The
Purchaser has taken no action that would give rise to any claim by any person for brokerage commissions, finders’ fees or the
like relating to this Subscription Agreement or the transactions contemplated hereby (other than otherwise described in the Memorandum);

 

(i)       The
Purchaser, together with its Advisers, if any, has such knowledge and experience in financial, tax, and business matters, and,
in particular, investments in securities, so as to enable it to utilize the information made available to it in connection with
the Offering to evaluate the merits and risks of an investment in the Units and the Company and to make an informed investment
decision with respect thereto;

 

(j)       The
Purchaser is not relying on the Company or any of their respective employees or agents with respect to the legal, tax, economic
and related considerations of an investment in the Units, and the Purchaser has relied on the advice of, or has consulted with,
only its own Advisers;

 

(k)       The
Purchaser is acquiring the Units solely for such Purchaser’s own account for investment purposes only and not with a view to or
intent of resale or distribution thereof, in whole or in part. The Purchaser has no agreement or arrangement, formal or informal,
with any person to sell or transfer all or any part of the Units or the Shares, and the Purchaser has no plans to enter into any
such agreement or arrangement;

 

(l)       The
Purchaser must bear the substantial economic risks of the investment in the Units indefinitely because none of the securities
included in the Units may be sold, hypothecated or otherwise disposed of unless subsequently registered under the Securities Act
and applicable state securities laws or an exemption from such registration is available. Legends shall be placed on the securities
included in the Units to the effect that they have not been registered under the Securities Act or applicable state securities
laws and appropriate notations thereof will be made in the Company’s books and records. Stop transfer instructions will be placed
with any registrar or transfer agent of the Shares comprising the Units, if other than the Company. There can be no assurance
any market will ever exist for the market for resale of the Shares comprising the Units nor can there be any assurance that such
securities will be freely transferable at any time in the foreseeable future;

 

    	 	III-3	 

     

    

 

(m)     The
Purchaser has adequate means of providing for such Purchaser’s current financial needs and foreseeable contingencies and has no
need for liquidity from its investment in the Units for an indefinite period of time;

 

(n)      The
Purchaser is aware that an investment in the Units is high risk, involving a number of very significant risks and has carefully
read and considered the matters set forth under the caption “Risk Factors” in the Memorandum, and, in particular, acknowledges
that the Company has a limited operating history, significant operating losses since inception, limited revenues to date, limited
assets and is engaged in a highly competitive business;

 

(o)      The
Purchaser meets the requirements of at least one of the suitability standards for an “accredited investor” as that term
is defined in Regulation D and as set forth on the Accredited Investor Certification contained herein;

 

(p)      The
Purchaser (i) if a natural person, represents that the Purchaser has reached the age of 21 and has full power and authority to
execute and deliver this Subscription Agreement and all other related agreements or certificates and to carry out the provisions
hereof and thereof; (ii) if a corporation, partnership, or limited liability company or partnership, or association, joint stock
company, trust, unincorporated organization or other entity, represents that such entity was not formed for the specific purpose
of acquiring the Units, such entity is duly organized, validly existing and in good standing under the laws of the state of its
organization, the consummation of the transactions contemplated hereby is authorized by, and will not result in a violation of
state law or its charter or other organizational documents, such entity has full power and authority to execute and deliver this
Subscription Agreement and all other related agreements or certificates and to carry out the provisions hereof and thereof and
to purchase and hold the securities constituting the Units, the execution and delivery of this Subscription Agreement has been
duly authorized by all necessary action, this Subscription Agreement has been duly executed and delivered on behalf of such entity
and is a legal, valid and binding obligation of such entity; or (iii) if executing this Subscription Agreement in a representative
or fiduciary capacity, represents that it has full power and authority to execute and deliver this Subscription Agreement in such
capacity and on behalf of the subscribing individual, ward, partnership, trust, estate, corporation, or limited liability company
or partnership, or other entity for whom the Purchaser is executing this Subscription Agreement, and such individual, partnership,
ward, trust, estate, corporation, or limited liability company or partnership, or other entity has full right and power to perform
pursuant to this Subscription Agreement and make an investment in the Company, and represents that this Subscription Agreement
constitutes a legal, valid and binding obligation of such entity. The execution and delivery of this Subscription Agreement will
not violate or be in conflict with any order, judgment, injunction, agreement or controlling document to which the Purchaser is
a party or by which it is bound;

 

(q)       The
Purchaser and its Advisers, if any, have had the opportunity to obtain any additional information, to the extent the Company has
such information in its possession or could acquire it without unreasonable effort or expense, necessary to verify the accuracy
of the information contained in the Memorandum and all documents received or reviewed in connection with the purchase of the Units
and have had the opportunity to have representatives of the Company provide them with such additional information regarding the
terms and conditions of this particular investment and the financial condition, results of operations, business of the Company
deemed relevant by the Purchaser or its Advisers, if any, and all such requested information, to the extent the Company had such
information in its possession or could acquire it without unreasonable effort or expense, has been provided to the full satisfaction
of the Purchaser and its Advisers, if any;

 

    	 	III-4	 

     

    

 

(r)       Any
information which the Purchaser has heretofore furnished or is furnishing herewith to the Company is complete and accurate and
may be relied upon by the Company in determining the availability of an exemption from registration under federal and state securities
laws in connection with the offering of securities as described in the Memorandum. The Purchaser further represents and warrants
that it will notify and supply corrective information to the Company immediately upon the occurrence of any change therein occurring
prior to the Company’s issuance of the securities contained in the Units;

 

(s)       The
Purchaser has significant prior investment experience, including investment in non-listed and non-registered securities. The Purchaser
is knowledgeable about investment considerations in development-stage companies with limited operating histories. The Purchaser
has a sufficient net worth to sustain a loss of its entire investment in the Company in the event such a loss should occur. The
Purchaser’s overall commitment to investments which are not readily marketable is not excessive in view of the Purchaser’s net
worth and financial circumstances and the purchase of the Units will not cause such commitment to become excessive. The investment
is a suitable one for the Purchaser;

 

(t)       The
Purchaser is satisfied that the Purchaser has received adequate information with respect to all matters which it or its Advisers,
if any, consider material to its decision to make this investment;

 

(u)       The
Purchaser acknowledges that any estimates or forward-looking statements or projections included in the Memorandum were prepared
by the Company in good faith but that the attainment of any such projections, estimates or forward-looking statements cannot be
guaranteed by the Company and should not be relied upon;

 

(v)       No
oral or written representations have been made, or oral or written information furnished, to the Purchaser or its Advisers, if
any, in connection with the Offering which are in any way inconsistent with the information contained in the Memorandum;

 

(w)       Within
five (5) days after receipt of a request from the Company, the Purchaser will provide such information and deliver such documents
as may reasonably be necessary to comply with any and all laws and ordinances to which the Company is subject;

 

(x)       THE
SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS
AND ARE BEING OFFERED AND SOLD IN RELIANCE ON EXEMPTIONS FROM THE REGISTRATION REQUIREMENTS OF SAID ACT AND SUCH LAWS. THE SECURITIES
ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER SAID
ACT AND SUCH LAWS PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. THE SECURITIES HAVE NOT BEEN RECOMMENDED, APPROVED OR DISAPPROVED
BY THE SECURITIES AND EXCHANGE COMMISSION, ANY STATE SECURITIES COMMISSION OR ANY OTHER REGULATORY AUTHORITY, NOR HAVE ANY OF
THE FOREGOING AUTHORITIES PASSED UPON OR ENDORSED THE MERITS OF THIS OFFERING OR THE ACCURACY OR ADEQUACY OF THE MEMORANDUM OR
THIS SUBSCRIPTION AGREEMENT. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL;

 

    	 	III-5	 

     

    

 

y)       In
making an investment decision investors must rely on their own examination of the Company and the terms of the Offering, including
the merits and risks involved. The Purchaser is aware that the Purchaser is required to bear the financial risks of this investment
for an indefinite period of time;

 

z)       (For
ERISA plans only) The fiduciary of the ERISA plan (the “Plan”) represents that such fiduciary has been informed
of and understands the Company’s investment objectives, policies and strategies, and that the decision to invest “plan assets”
(as such term is defined in ERISA) in the Company is consistent with the provisions of ERISA that require diversification of plan
assets and impose other fiduciary responsibilities. The Purchaser fiduciary or Plan (a) is responsible for the decision to invest
in the Company; (b) is independent of the Company or any of its affiliates; (c) is qualified to make such investment decision;
and (d) in making such decision, the Purchaser fiduciary or Plan has not relied primarily on any advice or recommendation of the
Company or any of its affiliates;

 

aa)     The
Purchaser should check the Office of Foreign Assets Control (“OFAC”) website at <http://www.treas.gov/ofac> before
making the following representations. The Purchaser represents that the amounts invested by it in the Company in the Offering
were not and are not directly or indirectly derived from activities that contravene federal, state or international laws and regulations,
including anti-money laundering laws and regulations. Federal regulations and Executive Orders administered by OFAC prohibit,
among other things, the engagement in transactions with, and the provision of services to, certain foreign countries, territories,
entities and individuals. The lists of OFAC prohibited countries, territories, persons and entities can be found on the OFAC website
at <http://www.treas.gov/ofac>. In addition, the programs administered by OFAC (the “OFAC Programs”) prohibit
dealing with individuals1 or entities in certain countries regardless of whether such individuals or entities appear
on the OFAC lists;

 

bb)     To
the best of the Purchaser’s knowledge, none of: (1) the Purchaser; (2) any person controlling or controlled by the Purchaser;
(3) if the Purchaser is a privately-held entity, any person having a beneficial interest in the Purchaser; or (4) any person for
whom the Purchaser is acting as agent or nominee in connection with this investment is a country, territory, individual or entity
named on an OFAC list, or a person or entity prohibited under the OFAC Programs. The Purchaser understands and acknowledges that
the Company may not accept any amounts from a prospective investor if such prospective investor cannot make the representation
set forth in the preceding paragraph. The Purchaser agrees to promptly notify the Company if the Purchaser becomes aware of any
change in the information set forth in these representations. The Purchaser understands and acknowledges that, by law, the Company
may be obligated to “freeze the account” of the Purchaser, either by prohibiting additional subscriptions from the Purchaser,
declining any redemption requests and/or segregating the assets in the account in compliance with governmental regulations. The
Purchaser further acknowledges that the Company may, by written notice to the Purchaser, suspend the redemption rights, if any,
of the Purchaser if the Company reasonably deems it necessary to do so to comply with anti-money laundering regulations applicable
to the Company or any of the Company’s other service providers. These individuals include specially designated nationals, specially
designated narcotics traffickers and other parties subject to OFAC sanctions and embargo programs;

 

 

1
These individuals include specially designated nationals, specially designated narcotics traffickers and other parties subject
to OFAC sanctions and embargo programs.

 

    	 	III-6	 

     

    

 

cc)      To
the best of the Purchaser’s knowledge, none of: (1) the Purchaser; (2) any person controlling or controlled by the Purchaser;
(3) if the Purchaser is a privately-held entity, any person having a beneficial interest in the Purchaser; or (4) any person for
whom the Purchaser is acting as agent or nominee in connection with this investment is a senior foreign political figure,2
or any immediate family3 member or close associate of a senior foreign political figure, as such terms are defined
in the footnotes below; and

 

dd)     If
the Purchaser is affiliated with a non-U.S. banking institution (a “Foreign Bank”), or if the Purchaser receives
deposits from, makes payments on behalf of, or handles other financial transactions related to a Foreign Bank, the Purchaser represents
and warrants to the Company that: (1) the Foreign Bank has a fixed address, other than solely an electronic address, in a country
in which the Foreign Bank is authorized to conduct banking activities; (2) the Foreign Bank maintains operating records related
to its banking activities; (3) the Foreign Bank is subject to inspection by the banking authority that licensed the Foreign Bank
to conduct banking activities; and (4) the Foreign Bank does not provide banking services to any other Foreign Bank that does
not have a physical presence in any country and that is not a regulated affiliate.

 

6.       Registration
Rights.

 

(a)       Definitions.
As used in Section 6, Section 7 and Section 8 of this Subscription Agreement, the following terms shall have the meanings
set forth below:

 

(i)       “Filing
Date” means the date that is one hundred and twenty (120) days after the Final Closing Date.

 

 

2
A “senior foreign political figure” is defined as a senior official in the executive, legislative, administrative,
military or judicial branches of a foreign government (whether elected or not), a senior official of a major foreign political
party, or a senior executive of a foreign government-owned corporation. In addition, a “senior foreign political figure”
includes any corporation, business or other entity that has been formed by, or for the benefit of, a senior foreign political
figure.

 

3
“Immediate family” of a senior foreign political figure typically includes the figure’s parents, siblings, spouse,
children and in-laws.

 

4
A “close associate” of a senior foreign political figure is a person who is widely and publicly known to maintain
an unusually close relationship with the senior foreign political figure, and includes a person who is in a position to conduct
substantial domestic and international financial transactions on behalf of the senior foreign political figure.

 

    	 	III-7	 

     

    

 

(ii)       “Final
Closing Date” means such date on which the last Closing occurs and after which the Company ceases to offer any Units
for sale in this Offering.

 

(iii)       The
terms “register,” “registered” and “registration” refer to a registration effected
by preparing and filing with the SEC a registration statement or similar document in compliance with the Securities Act, and the
declaration or ordering of effectiveness by the SEC of such registration statement or document.

 

(iv)       “Registrable
Securities” means all shares of Common Stock underlying the Units and any securities issued or then issuable upon any
stock split, dividend or other distribution, recapitalization or similar event with respect to the foregoing; provided, however,
that none of the foregoing shall be Registrable Securities if the holder thereof has not completed and delivered to the Company
a Selling Stockholder Questionnaire in the form attached to this Subscription Agreement; provided further, that any such Registrable
Securities shall cease to be Registrable Securities (i) upon any sale pursuant to the Registration Statement (as defined below)
or Rule 144 promulgated under the Securities Act, (ii) at such time such securities become eligible for resale without volume
or manner-of- sale restrictions pursuant to Rule 144, provided that at such time the Company is also in compliance with current
public information requirements, or (iii) upon becoming Remainder Shares.

 

(v)       “Rule
144” means Rule 144 as promulgated by the SEC under the Securities Act, as such rule may be amended from time to time,
or any similar successor rule that may be promulgated by the SEC.

 

(vi)       “Rule
415” means Rule 415 as promulgated by the SEC under the Securities Act, as such rule may be amended from time to time,
or any similar successor rule that may be promulgated by the SEC.

 

(vii)       “SEC
Guidance” means (i) any written or oral guidance, comments, interpretations, requirements or requests of the SEC staff
and (ii) the Securities Act and the rules and regulations promulgated thereunder.

 

(b)       Company
Registration.

 

(i)       On
or prior to the Filing Date, the Company shall prepare and file with the SEC one (1) registration statement (the “Registration
Statement”) covering the resale of the Registrable Securities in an offering to be made on a continuous basis pursuant
to Rule 415. The Registration Statement shall be on Form S-1 or, if the Company is so eligible, on Form S-3. The Company shall
use its commercially reasonable efforts to cause the Registration Statement to be declared effective under the Securities Act
as soon as reasonably possible. The Company shall use its commercially reasonable efforts to keep the Registration Statement continuously
effective under the Securities Act until all Registrable Securities covered by the Registration Statement have been sold, or may
be sold without the requirement to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant
to Rule 144, as determined by the counsel to the Company (the “Effectiveness Period”).

 

    	 	III-8	 

     

    

 

(ii)       If
the Registration Statement is not filed on or prior to the Filing Date (unless the reason for such non-registration of all or
any portion of the Registrable Securities is as a result of SEC Guidance under Rule 415 or similar rule which limits the number
of Registrable Securities which may be included in a registration statement with respect to the Purchaser) (any such failure to
file being referred to as an “Event”, and the date on which such Event occurs being referred to as an “Event
Date”), then as the exclusive remedy of Purchaser, on each thirty (30) day anniversary of the Event Date (if the Event
shall not have been cured by such date) until the Event is cured, the Company shall pay to the Purchaser an amount in cash, as
partial liquidated damages and not as a penalty, equal to one percent (1%) of the aggregate purchase price paid by the Purchaser
pursuant to this Subscription Agreement for such failure to file such number of securities as shall not have been included in
the Registration Statement on the Filing Date. The partial liquidated damages pursuant to the terms hereof shall apply on a daily
pro rata basis for any portion of a thirty (30) day period prior to the cure of an Event. Notwithstanding the foregoing, no payments
shall be owed with respect to any period during which all of the Purchaser’s Registrable Securities may be sold by such Purchaser
under Rule 144 without volume or manner-of-sale restrictions pursuant to Rule 144.

 

(iii)       Notwithstanding
the registration obligations set forth herein, in the event the SEC informs the Company that the Registrable Securities sought
to be registered by the Registration Statement cannot, as a result of the application of Rule 415 or similar rule or SEC Guidance
related thereto, be registered for resale as a secondary offering on a single registration statement, the Company shall promptly
inform the Purchaser thereof and shall use its commercially reasonable efforts to file an amendment to the Registration Statement
so that it covers the maximum number of Registrable Securities permitted by the SEC Guidance to be registered for resale as a
secondary offering on a single registration statement. Notwithstanding anything to the contrary in this Subscription Agreement,
(a) if any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered by the Registration
Statement, the number of Registrable Securities to be registered by the Registration Statement shall be reduced among all selling
stockholders named therein pro rata based on the number of Registrable Securities then held by each such selling stockholder,
unless a selling stockholder directs the Company in writing to register fewer of its Registrable Securities and subject to a determination
by the SEC that the Registrable Securities held by certain selling stockholder(s) must be reduced first, and (b) in the event
the Company amends, in accordance with this Section 6(b)(iii), the Registration Statement, the Company shall have no obligation
to file with the SEC any additional registration statement(s) to register for resale any of the shares of Common Stock Underlying
the Units that were not registered on the Registration Statement, as so amended (all such unregistered shares of Common Stock,
the “Remainder Shares”).

 

(iv)       The
Company shall bear and pay all expenses incurred in connection with any registration, filing or qualification of Registrable Securities
with respect to the registration required pursuant to this Section 6 for the Purchaser, including (without limitation) all registration,
filing and qualification fees, printer’s fees, accounting fees and fees and disbursements of counsel for the Company, but excluding
any brokerage or underwriting fees, discounts and commissions relating to Registrable Securities and fees and disbursements of
counsel for the Purchaser.

 

    	 	III-9	 

     

    

 

(c)       Obligations
of the Company. During the Effectiveness Period, the Company shall, as expeditiously as reasonably possible:

 

(i)       Furnish
to the Purchaser such numbers of copies of the prospectus, including any preliminary prospectus, contained in the Registration
Statement and filed in conformity with the requirements of the Securities Act, and such other documents as it may reasonably request
in order to facilitate the disposition of its Registrable Securities registered therein (provided that the Company shall not be
required to print or furnish such prospectuses if readily available to the Purchaser from any electronic service, such as on the
EDGAR filing database maintained at www.sec.gov);

 

(ii)       Use
its commercially reasonable efforts to register or qualify, unless an exemption from such registration or qualification is available,
the Registrable Securities covered by the Registration Statement under such other securities’ or blue sky laws of such jurisdictions
within the United States as shall be reasonably requested in writing by the Purchaser; provided that the Company shall not be
required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of
process in any such states or jurisdictions;

 

(iii)       Notify
the Purchaser, with respect to a prospectus relating to the Registrable Securities held by such Purchaser, within one business
day (i) after the effectiveness of the Registration Statement that includes such prospectus, or (ii) after the happening of any
event as a result of which the prospectus included in the Registration Statement, as then in effect, includes an untrue statement
of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein
not misleading in the light of the circumstances then existing; and

 

(iv)       Cause
all Registrable Securities registered pursuant hereto to be listed or quoted on each securities exchange or nationally recognized
quotation system on which similar securities issued by the Company are then listed or quoted.

 

7.       Obligations
of the Purchasers.

 

(a)       On
or prior to the Closing of the Purchaser’s subscription hereunder and on an annual basis thereafter as the Company may request
in connection with the preparation and filing of amendments to the Registration Statement, the Purchaser shall deliver to the
Company a completed Selling Stockholder Questionnaire. It shall be a condition precedent to the obligations of the Company that
such Purchaser shall furnish to the Company such information regarding itself, the Registrable Securities held by it and the intended
method of disposition of the Registrable Securities held by it as shall be reasonably required to timely effect such registration
of such Registrable Securities and shall execute such documents in connection with such registration as the Company may reasonably
request.

 

(b)       The
Purchaser, by such Purchaser’s acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested
by the Company in connection with the preparation and filing of the Registration Statement hereunder, unless such Purchaser has
notified the Company in writing of such Purchaser’s election to exclude all of such Purchaser’s Registrable Securities from the
Registration Statement.

 

    	 	III-10	 

     

    

 

(c)       Notwithstanding
anything to the contrary in this Subscription Agreement, at any time after the Registration Statement has been declared effective,
the Company may delay the disclosure of material non-public information concerning the Company, the disclosure of which at the
time is not, in the good faith opinion of the Board of Directors of the Company, in the best interest of the Company (the period
of such delay, a “Grace Period”), and during such Grace Period, after receipt of the notice described below,
the Purchaser shall not sell any Registrable Securities or any other securities of the Company that are held by such Purchaser
and shall not disclose to any third party that such a notice has been given or the contents of the notice; provided, that the
Company shall promptly (i) notify the Purchasers in writing of the existence of material non-public information giving rise to
a Grace Period (provided that in such notice the Company shall not disclose the contents of such material non-public information
to the Purchasers) and the date on which the Grace Period will begin, and (ii) notify the Purchasers in writing of the date on
which the Grace Period will end; and, provided further, that during any consecutive 365-day period, there shall be only three
(3) Grace Periods and any such Grace Period shall not exceed forty five (45) days (each, an “Allowable Grace Period”).
For purposes of determining the length of a Grace Period, a Grace Period shall begin on and include the date the Purchaser
receives the notice referred to in clause (i) above and shall end on and include the later of the date the Purchaser receives
the notice referred to in clause (ii) above and the date referred to in such notice.

 

(d)       Each
Purchaser agrees that, upon receipt of any notice from the Company (i) of the issuance of a stop order or other suspension of
effectiveness of the Registration Statement, or the suspension of the qualification of any of the Registrable Securities for sale
in any jurisdiction, (ii) of the happening of any event or the passage of time as a result of which the financial statements included
in the Registration Statement, as then in effect, are ineligible for inclusion therein or the prospectus included in the Registration
Statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be
stated therein or necessary to make the statements therein (in the case of any preliminary prospectus or final prospectus or amendments
or supplements thereto included in the Registration Statement, in light of the circumstances under which they were made) not misleading,
or (iii) pursuant to Section 7(c), such Purchaser will immediately discontinue disposition of all Registrable Securities pursuant
to the Registration Statement until, upon the occurrence of an event described in Sections 7(d)(i) or (ii), such Purchaser’s receipt
of the copies of, or notice of the filing on the EDGAR filing database maintained at www.sec.gov of, a supplement or amendment
to the Registration Statement and the prospectus included therein to correct such untrue statement or omission or update such
financial statements, or, upon the occurrence of an event described in Section 7(d)(iii), until the end of the applicable Grace
Period as specified in Section 7(c), and, if so directed by the Company, such Purchaser shall deliver to the Company (at the expense
of the Company) or destroy all copies of any prospectus covering such Registrable Securities in such Purchaser’s possession at
the time of the occurrence of any such event.

 

(e)       Each
Purchaser will comply with the prospectus delivery requirements of the Securities Act as applicable to it in connection with any
sales of Registrable Securities pursuant to the Registration Statement.

 

    	 	III-11	 

     

    

 

8.       Indemnification.

 

(a)       The
Purchaser agrees to indemnify and hold harmless the Company, and its officers, directors, employees, agents, control persons and
affiliates from and against all losses, liabilities, claims, damages, costs, fees and expenses whatsoever (including, but not
limited to, any and all expenses incurred in investigating, preparing or defending against any litigation commenced or threatened)
based upon or arising out of any actual or alleged false acknowledgment, representation or warranty, or misrepresentation or omission
to state a material fact, or breach by the Purchaser of any covenant or agreement made by the Purchaser herein or in any other
document delivered in connection with this Subscription Agreement.

 

(b)       The
Purchaser agrees to indemnify and hold harmless the Company and its officers, directors, employees, agents, control persons and
affiliates from and against all losses, liabilities, claims, damages, costs, fees and expenses whatsoever (including, but not
limited to, any and all expenses incurred in investigating, preparing or defending against any litigation commenced or threatened)
based upon or arising out of any untrue statement or alleged untrue statement of a material fact contained in the Registration
Statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto,
or omission to state a material fact required to be stated therein or necessary to make the statements therein (in the case of
any preliminary prospectus or final prospectus or amendments or supplements thereto, in light of the circumstances under which
they were made) not misleading, in each case to the extent (and only to the extent) that such losses, liabilities, claims, damages,
costs, fees and expenses arise out of (i) reliance upon and in conformity with written information furnished by the Purchaser
expressly for use in connection with such registration, including without limitation the information included in the Purchaser’s
Selling Stockholder Questionnaires delivered hereunder; provided, however, in no event shall any indemnity under this Section
8(b) exceed the net proceeds received by such Purchaser upon the sale of the Registrable Securities giving rise to such indemnification
obligation.

 

(c)       The
Company agrees to indemnify and hold harmless the Purchaser and its officers, directors, employees, agents, control persons and
affiliates from and against all losses, liabilities, claims, damages, costs, fees and expenses whatsoever (including, but not
limited to, any and all expenses incurred in investigating, preparing or defending against any litigation commenced or threatened)
based upon or arising out of any untrue statement or alleged untrue statement of a material fact contained in the Registration
Statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto,
or omission to state a material fact required to be stated therein or necessary to make the statements therein (in the case of
any preliminary prospectus or final prospectus or amendments or supplements thereto, in light of the circumstances under which
they were made) not misleading; provided, however, in no event shall the Company be liable under this Section 8(c) for any losses,
liabilities, claims, damages, costs, fees and expenses to the extent that such losses, liabilities, claims, damages, costs, fees
and expenses arise out of (i) reliance upon and in conformity with written information furnished expressly for use in connection
with such registration by the Purchaser or (ii) any of the circumstances set forth in Sections 8(b)(i), (ii) or (iii).

 

9.       Irrevocability;
Binding Effect. The Purchaser hereby acknowledges and agrees that the subscription hereunder is irrevocable by the Purchaser,
except as required by applicable law, and that this Subscription Agreement shall survive the death or disability of the Purchaser
and shall be binding upon and inure to the benefit of the parties and their heirs, executors, administrators, successors, legal
representatives, and permitted assigns. If the Purchaser is more than one person, the obligations of the Purchaser hereunder shall
be joint and several and the agreements, representations, warranties, and acknowledgments herein shall be deemed to be made by
and be binding upon each such person and such person’s heirs, executors, administrators, successors, legal representatives, and
permitted assigns.

 

    	 	III-12	 

     

    

 

10.       Modification.
This Subscription Agreement shall not be modified or waived except by an instrument in writing signed by the party against
whom any such modification or waiver is sought.

 

11.       Notices.
Any notice or other communication required or permitted to be given hereunder shall be in writing and shall be deemed effectively
given: (a) upon personal delivery to the party notified, (b) when sent by confirmed email or facsimile if sent during normal business
hours of the recipient, if not, then on the next business day, (c) five days after having been sent by registered or certified
mail, return receipt requested, postage prepaid, or (d) one day after deposit with a nationally recognized overnight courier,
specifying next day delivery, with written verification of receipt. All communications shall be sent to the parties at their respective
address, email or facsimile number set forth on the signature page hereto, or to such other address as such party shall have furnished
in writing in accordance with the provisions of this Section 11.

 

12.       Assignability.
This Subscription Agreement and the rights, interests and obligations hereunder are not transferable or assignable by the
Purchaser and the transfer or assignment of the Shares shall be made only in accordance with all applicable laws.

 

13.       Applicable
Law. This Subscription Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable
to contracts to be wholly-performed within said State.

 

14.       Blue
Sky Qualification. The purchase of Units under this Subscription Agreement is expressly conditioned upon the exemption from
qualification of the offer and sale of the Units from applicable federal and state securities laws. The Company shall not be required
to qualify this transaction under the securities laws of any jurisdiction and, should qualification be necessary, the Company
shall be released from any and all obligations to maintain its offer, and may rescind any sale contracted, in the jurisdiction.

 

15.       Use
of Pronouns. All pronouns and any variations thereof used herein shall be deemed to refer to the masculine, feminine, neuter,
singular or plural as the identity of the person or persons referred to may require.

 

16.       Confidentiality.
The Purchaser acknowledges and agrees that any information or data the Purchaser has acquired from or about the Company, not
otherwise properly in the public domain, was received in confidence. The Purchaser agrees not to divulge, communicate or disclose,
except as may be required by law or for the performance of this Subscription Agreement, or use, or misuse in any way, any confidential
information of the Company, including any scientific, technical, trade or business secrets of the Company and any scientific,
technical, trade or business materials that are treated by the Company as confidential or proprietary, including, but not limited
to, ideas, discoveries, inventions, developments and improvements belonging to the Company and confidential information obtained
by or given to the Company about or belonging to third parties.

 

    	 	III-13	 

     

    

 

17.      Miscellaneous.

 

(a)       This
Subscription Agreement, including all attachments, schedules and exhibits thereto, constitutes the entire agreement between the
Purchaser and the Company with respect to the subject matter hereof and supersede all prior oral or written agreements and understandings,
if any, relating to the subject matter hereof.

 

(b)       The
representations and warranties of the Purchaser made in this Subscription Agreement shall survive the execution and delivery hereof
and delivery of the Shares underlying the Units.

 

(c)       Each
of the parties hereto shall pay its own fees and expenses (including the fees of any attorneys, accountants, appraisers or others
engaged by such party) in connection with this Subscription Agreement and the transactions contemplated hereby whether or not
the transactions contemplated hereby are consummated.

 

(d)       This
Subscription Agreement may be executed in one or more counterparts each of which shall be deemed an original, but all of which
shall together constitute one and the same instrument.

 

(e)       Each
provision of this Subscription Agreement shall be considered separable and, if for any reason any provision or provisions hereof
are determined to be invalid or contrary to applicable law, such invalidity or illegality shall not impair the operation of or
affect the remaining portions of this Subscription Agreement.

 

(f)       Paragraph
and Section titles are for convenience and descriptive purposes only and are not to be considered in construing or interpreting
this Subscription Agreement.

 

(g)       The
Purchaser understands and acknowledges that there may be multiple closings for this Offering.

 

18.       Lockup.
The Purchaser shall enter into and abide by the terms of a lockup agreement substantially in the form attached as Annex B
to the Memorandum.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]

HEALTHLYNKED CORP.

OMNIBUS
SIGNATURE PAGE TO THE SUBSCRIPTION AGREEMENT

 

Purchaser
hereby elects to subscribe under the Subscription Agreement for a total of 20 Units at a price of $5,000 per Unit, $50,000 or
625,000 shares of HealthLynked Corporation at $0.08 per share and, by execution and delivery hereof (return two (2) originals),
Purchaser hereby executes the Subscription Agreement and agrees to be bound by the terms and conditions of the Subscription Agreement.

 

Date:
___________________________________________________

 

    	 	III-14	 

     

    

 

If the Purchaser is an INDIVIDUAL,
and if purchased as JOINT TENANTS, as TENANTS IN COMMON, or as COMMUNITY PROPERTY:

 

	 	 	 
	Print
    Name(s)	 	Social
    Security Number(s)
	 	 	 
	 	 	 
	Signature(s)
    of Purchaser(s)	 	Signature
	 	 	 
	 	 	 
	Date	 	Address
	 	 	 
	 	 	 
	Fax
    Number	 	Email
    Address

 

If
the Purchaser is a PARTNERSHIP, CORPORATION, LIMITED LIABILITY COMPANY or TRUST:

 

	 	 	 
	Name
    of Entity	 	Federal
    Tax Identification Number
	 	 	 	 
	By:	 	 	
	 	Name:
    	 	State
of Organization
	 	Title:	 	 
	 	 	 	 
	 	 	 
	Date
    	 	 
	 	 	 
	 	 	 
	Fax
    Number	 	Email
    Address

 

    	 	III-15	 

     

    

 

	Accepted:	 
	HEALTHLYNKED
    CORP.	 
	 	 
	By:	 	 
	 	Authorized
    Officer	 
	 	 	 
	 	 
	Address	 
	 	 
	 	 
	Fax
    Number	 
	 	 
	 	 
	Email
    Address	 

 

    	 	III-16	 

     

    

 

PRIVATE
PLACEMENT OFFERING OF

HEALTHLYNKED CORP.

 

SUBSCRIPTION
INSTRUCTIONS 

 

To
subscribe for Units in the private offering of HealthLynked Corp.

 

		1.	Date
                                         and Fill in the number of Units being purchased and Complete and Sign two
                                         (2) copies of the Omnibus Signature Page to the Subscription Agreement (page 15).

 

		2.	Initial
                                         the Accredited Investor Certification page attached to the Subscription Agreement
                                         (pages 18-19).

 

		3.	E-mail
                                         all forms to Dr. Michael Dent at mdentl@comcast.net or George O’Leary at goleary@sksconsulting.us
                                         and then send all signed original documents to:

 

Dr.
Michael Dent

HealthLynked Corp.

1726
Medical Blvd Suite 101

Naples,
Florida 34110

 

	5.	Please wire funds directly to HealthLynked Corp.
pursuant to the following instructions (unless other arrangements have been made):

 

Wells
Fargo Bank, N.A.

420 Montgomery

San
Francisco CA 94104

Routing Number: 121000248

 

HealthLynked
Corporation

1726
Medical Blvd.

Naples FL 34110

Account
Number: 7092859870

 

    	 	III-17	 

     

    

 

HEALTHLYNKED
CORP.

 

ACCREDITED
INVESTOR CERTIFICATION

 

For
Individual Investors Only

(all
Individual Investors must INITIAL where appropriate):

 

	Initial
    ______________	I
    have an individual net worth, or joint net worth with my spouse, as of the date hereof in excess of $1 million. For purposes
    of calculating net worth under this category, (i) the undersigned’s primary residence shall not be included as an asset, (ii)
    indebtedness that is secured by the undersigned’s primary residence, up to the estimated fair market value of the primary
    residence at the time of the sale of securities, shall not be included as a liability, (iii) to the extent that the indebtedness
    that is secured by the primary residence is in excess of the fair market value of the primary residence, the excess amount
    shall be included as a liability, and (iv) if the amount of outstanding indebtedness that is secured by the primary residence
    exceeds the amount outstanding 60 days prior to the execution of this Subscription Agreement, other than as a result of the
    acquisition of the primary residence, the amount of such excess shall be included as a liability.
	 	 
	Initial
    ______________	I
    have had an annual gross income for the past two years of at least $200,000 (or $300,000 jointly with my spouse) and expect
    my income (or joint income, as appropriate) to reach the same level in the current year.
	 	 
	Initial
    ______________	 I
    am a director or executive officer of HealthLynked Corp. (the “Company”)

 

For
Non-Individual Investors

(all
Non-Individual Investors must INITIAL where appropriate):

 

	Initial
    ______________	The
    investor certifies that it is a partnership, corporation, limited liability company or business trust that is 100% owned by
    persons who meet at least one of the criteria for Individual Investors set forth above.
	 	 
	Initial
    ______________	The
    investor certifies that it is a partnership, corporation, limited liability company or any organization described in Section
    501(c)(3) of the Internal Revenue Code, Massachusetts or similar business trust that has total assets of at least $5 million
    and was not formed for the purpose of investing the Company.
	 	 
	Initial
    ______________	The
    investor certifies that it is an employee benefit plan within the meaning of the Employee Retirement Income Security Act of
    1974, whose investment decision is made by a plan fiduciary (as defined in ERISA §3(21)) that is a bank, savings and
    loan association, insurance company or registered investment adviser.
	 	 
	Initial
    ______________	The
    investor certifies that it is an employee benefit plan whose total assets exceed $5,000,000 as of the date of this certification.

 

    	 	III-18	 

     

    

 

	Initial
    ______________	The
    undersigned certifies that it is a self-directed employee benefit plan whose investment decisions are made solely by persons
    who meet either of the criteria for Individual Investors.
	 	 
	Initial
    ______________	The
    investor certifies that it is a U.S. bank, U.S. savings and loan association or other similar U.S. institution acting in its
    individual or fiduciary capacity.
	 	 
	Initial
    ______________	The
    undersigned certifies that it is a broker-dealer registered pursuant to §15 of the Securities Exchange Act of 1934, as
    amended.
	 	 
	Initial
    ______________	The
    investor certifies that it is an organization described in §501(c)(3) of the Internal Revenue Code with total assets
    exceeding $5,000,000 and not formed for the specific purpose of investing in the Company.
	 	 
	Initial
    ______________	The
    investor certifies that it is a trust with total assets of at least $5,000,000, not formed for the specific purpose of investing
    in the Company, and whose purchase is directed by a person with such knowledge and experience in financial and business matters
    that he is capable of evaluating the merits and risks of the prospective investment.
	 	 
	Initial
    ______________ 	The
    investor certifies that it is a plan established and maintained by a state or its political subdivisions, or any agency or
    instrumentality thereof, for the benefit of its employees, and which has total assets in excess of $5,000,000.
	 	 
	Initial
    ______________	The
    investor certifies that it is an insurance company as defined in §2(13) of the Securities Act, or a registered investment
    company.
	 	 
	Initial
    ______________	The
    investor certifies that it is an investment company registered under the Investment Company Act of 1940, as amended, or a
    business development company as defined in Section 2(a)(48) of that Act.
	 	 
	Initial
    ______________	The
    investor certifies that it is a Small Business Investment Company licensed by the U.S. Small Business Administration under
    Section 301(c) or (d) of the Small Business Investment Act of 1958, as amended.
	 	 
	Initial
    ______________	The
    investor certifies that it is a private business development company as defined in Section 202(a)(22) of the Investment Advisers
    Act of 1940, as amended.

 

    	 	III-19	 

     

    

 

SELLING
STOCKHOLDER QUESTIONNAIRE

 

The
undersigned holder of shares of the common stock of HealthLynked Corp., a Nevada corporation (the “Company”), issued
pursuant to the Subscription Agreement by and between the Company and the undersigned (the “Agreement”) (all
or a portion of such shares, the “Registrable Securities”), understands that the Company intends to file with
the Securities and Exchange Commission (the “SEC”) one or more registration statements (each, a “Registration
Statement”) for the registration and the resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities
Act”), of the Registrable Securities in accordance with the terms of the Agreement. All capitalized terms not otherwise
defined herein shall have the meanings given to them in the Agreement.

 

In
order to sell or otherwise dispose of any Registrable Securities pursuant to a Registration Statement, a holder of Registrable
Securities generally will be required to be named as a selling stockholder in the related prospectus or a supplement thereto (as
so supplemented, the “Prospectus”), deliver the Prospectus to purchasers of Registrable Securities (including
pursuant to Rule 172 under the Securities Act) and be bound by the provisions of the Agreement (including certain indemnification
provisions). Holders must also complete and deliver this Selling Stockholder Questionnaire in order to be named as selling stockholders
in the Prospectus. Holders of Registrable Securities who do not complete, execute and return this Selling Stockholder Questionnaire
on or before the date(s) specified in the Agreement (1) will not be named as selling stockholders in a Registration Statement
or the Prospectus and (2) may not use the Prospectus for re-sales of Registrable Securities.

 

Certain
legal consequences arise from being named as a selling stockholder in a Registration Statement and the Prospectus. Holders of
Registrable Securities are advised to consult their own counsel regarding the consequences of being named or not named as a selling
stockholder in a Registration Statement and the Prospectus.

 

	1.	Name.

 

		(a)	Full
                                         Legal Name of the Selling Stockholder:

 

 

 

 

 

 

		(b)	Full
                                         Legal Name of Registered Holder (if not the same as (a) above) through which Registrable
                                         Securities listed in Item 3 below are held:

 

 

 

 

 

 

 

 

 

    	 	III-20	 

     

    

 

		(c)	If
                                         the Selling Stockholder is not a Natural Person, the Full Legal Name of the Natural Control
                                         Persons (which means the natural person(s) who directly or indirectly, alone or with
                                         others, has the power to vote or dispose of the securities covered by this Selling Stockholder
                                         Questionnaire):

 

 

 

 

 

 

 

	2.	Contact
    Information for Notices to Selling Stockholder relating to the Registration Statement.

 

Contact
Person:

 

Fax
No. for Contact Person: __________________________________________________________________________

 

Email
address of Contact Person:

 

	3.	Beneficial
    Ownership of Registrable Securities.

 

		(a)	Type
                                         and Number of Registrable Securities beneficially owned and issued pursuant to the Agreement:

 

625,000
common shares of HealthLynked Corporation

 

 

 

 

 

 

 

		(b)	Number
                                         of shares of Registrable Securities listed in Item 3(a) that the Selling Stockholder
                                         requests be registered for resale pursuant to a Registration Statement:

 

625,000
shares of HealthLynked Corporation

 

 

 

 

 

 

 

	4.	Broker-Dealer
    Status of Affiliation.

 

	 	(a)	Are
    you a broker-dealer?

 

	 	Yes
    _______________________	No
    ☒

 

    	 	III-21	 

     

    

 

		(b)	If
                                         “yes” to Section 4(a), did you receive your Registrable Securities as compensation
                                         for investment banking services to the Company?

 

	 	Yes
    _______________________	No
    _______________________

 

Note:
If no, the SEC’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

	(c)	Are
    you an affiliate of a broker-dealer?

 

	 	Yes
    _______________________	No
    ☒

 

If
yes, provide a narrative explanation below:

 

		(c)	If
                                         you are an affiliate of a broker-dealer, do you certify that you bought the Registrable
                                         Securities in the ordinary course of business, and at the time of the purchase of the
                                         Registrable Securities to be resold, you had no agreements or understandings, directly
                                         or indirectly, with any person to distribute the Registrable Securities?

 

	 	Yes
    _______________________	No
    _______________________

 

Note:
If no, the SEC’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

	5.	Beneficial
    Ownership of Other Securities of the Company Owned by the Selling Stockholder.

 

Except
as set forth below in this Item 5, the undersigned is not the beneficial or registered owner of any securities of the Company
other than the Registrable Securities listed above in Item 3.

 

	 	(a)	Type
    and amount of other securities of the Company beneficially owned (if none, so state):

 

 

 

 

 

 

 

 

 

	6.	Relationships
    with the Company.

 

Except
as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners
of 5% of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship
with the Company (or its predecessors or affiliates) during the past three years.

 

    	 	III-22	 

     

    

 

State
any exceptions here:

 

                                                             NONE

 

 

 

 

 

*
* *

 

The
undersigned agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein that may
occur subsequent to the date hereof and prior to the effective date of the Registration Statement and at any time while the
Registration Statement remains effective. All notices by the undersigned hereunder and pursuant to the Agreement shall be
made in writing and delivered as set forth in the Agreement. In the absence of any such notification, the Company shall be
entitled to rely and continue to rely on the accuracy of the information in this Selling Stockholder
Questionnaire.

 

The
undersigned also acknowledges that the answers to Items (1) through (6) in this Selling Stockholder Questionnaire are furnished
for use in connection with a Registration Statement to be filed pursuant to the Agreement and any amendments or supplements thereto
filed with the SEC pursuant to the Securities Act. By signing below, the undersigned consents to the disclosure of its answers
to Items (1) through (6) and the inclusion of such information in any Registration Statement and any Prospectus. The undersigned
understands that such information will be relied upon by the Company in connection with the preparation or amendment of any such
Registration Statement and any such Prospectus.

 

By
signing below, the undersigned acknowledges that it understands its obligation to comply, and agrees that it will comply, with
the provisions of the Exchange Act of 1934, as amended, and the rules and regulations thereunder, particularly Regulation M in
connection with any offering of Registrable Securities pursuant to a Registration Statement.

 

The
undersigned hereby acknowledges and is advised of the following Division of Corporation Financing Compliance and Disclosure Interpretation
239.10 regarding short selling:

 

“An
issuer filed a Form S-1 registration statement for a secondary offering of common stock which is not yet effective. One of the
selling shareholders wanted to do a short sale of common stock “against the box” and cover the short sale with registered
shares after the effective date. The issuer was advised that the short sale could not be made before the registration statement
becomes effective, because the shares underlying the short sale are deemed to be sold at the time such sale is made. There would,
therefore, be a violation of Section 5 if the shares were effectively sold prior to the effective date.”

 

By
completing, signing and returning this Selling Stockholder Questionnaire, the undersigned will be deemed to be aware of the foregoing
interpretation. The acknowledgements by and agreements of the undersigned set forth in this Selling Stockholder Questionnaire
shall be in addition to, and shall not limit the
scope and applicability of, the representations, warranties and covenants made by the undersigned in the Agreement.

 

    	 	III-23	 

     

    

 

The
undersigned represents, warrants and certifies that, to the best of its knowledge and belief, the foregoing statements (including
without limitation the answers to Items (1) through (6) in this Selling Stockholder Questionnaire) are correct and complete.

 

*
* *

 

IN
WITNESS WHEREOF the undersigned, by authority duly given, has caused this Selling Stockholder Questionnaire to be executed
and delivered either in person or by its duly authorized agent.

 

 

	 	 	 	Selling
    Stockholder:
	 	 	 	 	 
	Dated: 	 	 	By:	 
	 	 	 	Name:	 
	 	 	 	Title:	 

	                    	                     	Email
    Address:	                     

 

PLEASE
RETURN THE COMPLETED AND EXECUTED SELLING STOCKHOLDER

QUESTIONNAIRE IN ACCORDANCE WITH THE INSTRUCTIONS SET FORTH IN THE

“SUBSCRIPTION INSTRUCTIONS” ATTACHED TO THE AGREEMENT.

 

 

III-24

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00266-of-00352.parquet"}]]